<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: QXInteractive; Version: 5.6b -->
    <!-- Field: Doc-Info; Name: Source; Value: 213578 12312020 10KA.xfr; Date: 2021%2D05%2D11T23:29:00Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:BRPAU="http://bigrockpartners.com/20201231">
    <link:schemaRef xlink:href="brpau-20201231.xsd" xlink:type="simple" />
    <xbrli:context id="AsOf2019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_NonredeemableCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BRPAU:NonredeemableCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_NonredeemableCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BRPAU:NonredeemableCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_RedeemableCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BRPAU:RedeemableCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_RedeemableCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BRPAU:RedeemableCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-05-07">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-05-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_srt_RestatementAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_srt_RestatementAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_NonredeemableCommonStockMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BRPAU:NonredeemableCommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_NonredeemableCommonStockMember_srt_RestatementAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BRPAU:NonredeemableCommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001719406</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Percent">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <dei:EntityRegistrantName contextRef="From2020-01-01to2020-12-31">Big Rock Partners Acquisition Corp.</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey contextRef="From2020-01-01to2020-12-31">0001719406</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2020-01-01to2020-12-31">10-K/A</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2020-01-01to2020-12-31">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:AmendmentFlag contextRef="From2020-01-01to2020-12-31">true</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2020-01-01to2020-12-31">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2020-01-01to2020-12-31">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2020-01-01to2020-12-31">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2020-01-01to2020-12-31">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityFilerCategory contextRef="From2020-01-01to2020-12-31">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany contextRef="From2020-01-01to2020-12-31">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2020-01-01to2020-12-31">false</dei:EntityExTransitionPeriod>
    <dei:EntitySmallBusiness contextRef="From2020-01-01to2020-12-31">true</dei:EntitySmallBusiness>
    <dei:EntityShellCompany contextRef="From2020-01-01to2020-12-31">true</dei:EntityShellCompany>
    <dei:EntityInteractiveDataCurrent contextRef="From2020-01-01to2020-12-31">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityIncorporationStateCountryCode contextRef="From2020-01-01to2020-12-31">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2020-01-01to2020-12-31">001-38302</dei:EntityFileNumber>
    <dei:DocumentFiscalPeriodFocus contextRef="From2020-01-01to2020-12-31">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="From2020-01-01to2020-12-31">2020</dei:DocumentFiscalYearFocus>
    <us-gaap:Cash contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">6</us-gaap:Cash>
    <us-gaap:Cash contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">466</us-gaap:Cash>
    <us-gaap:Cash contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">11079</us-gaap:Cash>
    <us-gaap:AssetsCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">69489</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">82458</us-gaap:AssetsCurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">32005205</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent contextRef="AsOf2019-12-31_us-gaap_FairValueInputsLevel1Member" unitRef="USD" decimals="0">32005205</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">5967947</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent contextRef="AsOf2020-12-31_us-gaap_FairValueInputsLevel1Member" unitRef="USD" decimals="0">5967947</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:Assets contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">32074694</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">6050405</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">622441</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">609509</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:Liabilities contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">2574205</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">3936644</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2020-12-31_srt_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">3281546</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2020-12-31_srt_RestatementAdjustmentMember" unitRef="USD" decimals="0">655098</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">24500488</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockValue contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">2844</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">2688</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">4627662</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">2831088</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">369495</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">-720015</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2020-12-31_srt_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">-64917</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2020-12-31_srt_RestatementAdjustmentMember" unitRef="USD" decimals="0">-655098</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">5000001</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">2844</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">4627662</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">369495</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">2113761</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">2688</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">2831088</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-720015</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">2725</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">5036213</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-38932</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">5000006</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_srt_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">2768859</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_srt_RestatementAdjustmentMember" unitRef="USD" decimals="0">-655098</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">32074694</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">6050405</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:TemporaryEquitySharesOutstanding contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">2301335</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding contextRef="AsOf2020-12-31" unitRef="Shares" decimals="INF">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2019-12-31" unitRef="USDPShares" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2020-12-31" unitRef="USDPShares" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2020-12-31" unitRef="Shares" decimals="INF">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2020-12-31" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2020-12-31" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2019-12-31" unitRef="USDPShares" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2020-12-31" unitRef="USDPShares" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2020-12-31" unitRef="Shares" decimals="INF">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">2844414</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2020-12-31" unitRef="Shares" decimals="INF">2688242</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">2844414</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2020-12-31" unitRef="Shares" decimals="INF">2688242</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:OperatingExpenses contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">907406</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">713187</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-907406</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-713187</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-1071669</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">492633</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2020-01-01to2020-12-31_srt_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">-416571</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2020-01-01to2020-12-31_srt_RestatementAdjustmentMember" unitRef="USD" decimals="0">-655098</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">17841</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">84206</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-1089510</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-1089510</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">408427</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">408427</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2020-01-01to2020-12-31_srt_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">-434412</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2020-01-01to2020-12-31_srt_RestatementAdjustmentMember" unitRef="USD" decimals="0">-655098</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2020-01-01to2020-12-31_custom_NonredeemableCommonStockMember" unitRef="Shares" decimals="INF">2736258</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2019-01-01to2019-12-31_custom_NonredeemableCommonStockMember" unitRef="Shares" decimals="INF">2783021</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2020-01-01to2020-12-31_custom_RedeemableCommonStockMember" unitRef="Shares" decimals="INF">546586</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2019-01-01to2019-12-31_custom_RedeemableCommonStockMember" unitRef="Shares" decimals="INF">4555229</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2020-01-01to2020-12-31_custom_NonredeemableCommonStockMember" unitRef="USDPShares" decimals="INF">-.40</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2019-01-01to2019-12-31_custom_NonredeemableCommonStockMember" unitRef="USDPShares" decimals="INF">-.11</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2020-01-01to2020-12-31_custom_RedeemableCommonStockMember" unitRef="USDPShares" decimals="INF">0.00</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2019-01-01to2019-12-31_custom_RedeemableCommonStockMember" unitRef="USDPShares" decimals="INF">0.15</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2020-01-01to2020-12-31_custom_NonredeemableCommonStockMember_srt_ScenarioPreviouslyReportedMember" unitRef="USDPShares" decimals="INF">-.16</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2020-01-01to2020-12-31_custom_NonredeemableCommonStockMember_srt_RestatementAdjustmentMember" unitRef="USDPShares" decimals="INF">-.24</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:SharesOutstanding contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">2844414</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">2688242</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2018-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">2725039</us-gaap:SharesOutstanding>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">280000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">280000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:MarketableSecuritiesGainLoss contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">138764</us-gaap:MarketableSecuritiesGainLoss>
    <us-gaap:MarketableSecuritiesGainLoss contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">1205820</us-gaap:MarketableSecuritiesGainLoss>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">30350</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-19114</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-17841</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">69483</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">339139</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">71342</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">0</us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-16311</us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-598617</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-792731</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <BRPAU:CashWithdrawnFromTrustAccountToPayRedeemingStockholders contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">26297218</BRPAU:CashWithdrawnFromTrustAccountToPayRedeemingStockholders>
    <BRPAU:CashWithdrawnFromTrustAccountToPayRedeemingStockholders contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">40726687</BRPAU:CashWithdrawnFromTrustAccountToPayRedeemingStockholders>
    <BRPAU:CashWithdrawnFromTrustAccountToPayFranchiseTaxes contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">161430</BRPAU:CashWithdrawnFromTrustAccountToPayFranchiseTaxes>
    <BRPAU:CashWithdrawnFromTrustAccountToPayFranchiseTaxes contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">512993</BRPAU:CashWithdrawnFromTrustAccountToPayFranchiseTaxes>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">26176022</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">40246581</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromNotesPayable contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">274266</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">845623</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromRelatedPartyDebt contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">481007</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">481141</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">35000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">65000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-26297218</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-40726687</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-25576945</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-39464923</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">460</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-11073</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:IncomeTaxesPaidNet contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">170000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:TemporaryEquityIssuePeriodIncreaseOrDecrease contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">414583</us-gaap:TemporaryEquityIssuePeriodIncreaseOrDecrease>
    <us-gaap:TemporaryEquityIssuePeriodIncreaseOrDecrease contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">688432</us-gaap:TemporaryEquityIssuePeriodIncreaseOrDecrease>
    <BRPAU:CapitalContributionToTrustAccounts contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">0</BRPAU:CapitalContributionToTrustAccounts>
    <BRPAU:CapitalContributionToTrustAccounts contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">280000</BRPAU:CapitalContributionToTrustAccounts>
    <dei:EntityIncorporationDateOfIncorporation contextRef="From2020-01-01to2020-12-31">2017-09-18</dei:EntityIncorporationDateOfIncorporation>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">0</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">105559</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsUnrealizedLossesOnTradingSecurities contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">0</us-gaap:DeferredTaxAssetsUnrealizedLossesOnTradingSecurities>
    <us-gaap:DeferredTaxAssetsUnrealizedLossesOnTradingSecurities contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">0</us-gaap:DeferredTaxAssetsUnrealizedLossesOnTradingSecurities>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">0</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">105559</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">0</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">105559</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">0</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">0</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">17841</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">102332</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-87480</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">2936</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">0</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">0</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-18079</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">0</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredOtherTaxExpenseBenefit contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">105559</us-gaap:DeferredOtherTaxExpenseBenefit>
    <us-gaap:DeferredOtherTaxExpenseBenefit contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-21062</us-gaap:DeferredOtherTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="From2020-01-01to2020-12-31" unitRef="Percent" decimals="INF">.2100</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="From2019-01-01to2019-12-31" unitRef="Percent" decimals="INF">.2100</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="From2020-01-01to2020-12-31" unitRef="Percent" decimals="INF">.0430</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="From2019-01-01to2019-12-31" unitRef="Percent" decimals="INF">.0000</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="From2020-01-01to2020-12-31" unitRef="Percent" decimals="INF">-.0170</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="From2019-01-01to2019-12-31" unitRef="Percent" decimals="INF">.0040</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="From2020-01-01to2020-12-31" unitRef="Percent" decimals="INF">-.0990</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="From2019-01-01to2019-12-31" unitRef="Percent" decimals="INF">-.0430</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="From2020-01-01to2020-12-31" unitRef="Percent" decimals="INF">-.0170</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="From2019-01-01to2019-12-31" unitRef="Percent" decimals="INF">.1710</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <dei:EntityPublicFloat contextRef="AsOf2020-06-30" unitRef="USD" decimals="0">6100000</dei:EntityPublicFloat>
    <us-gaap:PrepaidTaxes contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">0</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">51642</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">69483</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">30350</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:NotesPayableCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">1535623</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">1809889</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">416141</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">862148</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <us-gaap:InterestIncomeExpenseNet contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">138764</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">1205820</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-164263</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">1205820</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2020-01-01to2020-12-31_srt_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">490835</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2020-01-01to2020-12-31_srt_RestatementAdjustmentMember" unitRef="USD" decimals="0">-655098</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">352071</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:StockIssuedDuringPeriodSharesOther contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">414583</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodSharesOther contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">119375</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-1538815</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">-132</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">-1538683</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">-27786</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-299253</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">-28</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">-299225</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:PaymentsToAcquireInvestments contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">282626</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">993099</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;Big Rock Partners Acquisition&#13;Corp. (the &amp;#8220;Company&amp;#8221;) is a blank check company incorporated in Delaware on September 18, 2017. The Company was formed&#13;for the purpose of acquiring, through a merger, share exchange, asset acquisition, stock purchase, reorganization, recapitalization,&#13;or other similar business transaction, one or more operating businesses or entities (a &amp;#8220;Business Combination&amp;#8221;). The&#13;Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;The Company has one subsidiary,&#13;Big Rock Merger Corp., a wholly-owned subsidiary of the Company incorporated in Delaware on January 22, 2019 (&amp;#8220;Merger Sub&amp;#8221;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;All activity through December&#13;31, 2020 relates to the Company&amp;#8217;s formation, its initial public offering (&amp;#8220;Initial Public Offering&amp;#8221;), which is&#13;described below, identifying a target company for a Business Combination, and activities in connection with the proposed acquisition&#13;of NeuroRx, Inc., a Delaware corporation (&amp;#8220;&lt;u&gt;NeuroRx&lt;/u&gt;&amp;#8221;) (see Note 8).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;The registration statement&#13;for the Company&amp;#8217;s Initial Public Offering was declared effective on November 20, 2017. On November 22, 2017, the Company&#13;consummated the Initial Public Offering of 6,000,000 units (the &amp;#8220;Units&amp;#8221; and, with respect to the common stock included&#13;in the Units being offered, the &amp;#8220;Public Shares&amp;#8221;), generating gross proceeds of $60,000,000, which is described in Note&#13;4. Each Unit consists of one share of common stock, one right (&amp;#8220;Public Right&amp;#8221;) and one-half of one warrant (&amp;#8220;Public&#13;Warrant&amp;#8221;). Each Public Right will convert into one-tenth (1/10) of one share of common stock upon consummation of a Business&#13;Combination. Each whole Public Warrant entitles the holder to purchase one share of common stock at an exercise price of $11.50&#13;per whole share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;Simultaneously with the&#13;Initial Public Offering, the Company consummated the sale of 250,000 units (the &amp;#8220;Private Placement Units&amp;#8221;) at a price&#13;of $10.00 per Unit in a private placement to Big Rock Partners Sponsor, LLC (the &amp;#8220;Sponsor&amp;#8221;), generating gross proceeds&#13;of $2,500,000, which is described in Note 5.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;Following the closing of&#13;the Initial Public Offering, $60,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public&#13;Offering and the Private Placement Units was placed in a trust account (the &amp;#8220;Trust Account&amp;#8221;) which may be invested&#13;in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended&#13;(the &amp;#8220;Investment Company Act&amp;#8221;), with a maturity of 180 days or less or in any open-ended investment company that holds&#13;itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as&#13;determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the&#13;Trust Account, as described below.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;On November 29, 2017, in&#13;connection with the underwriters&amp;#8217; exercise of their over-allotment option in full, the Company consummated the sale of an&#13;additional 900,000 Units, and the sale of an additional 22,500 Private Placement Units at $10.00 per unit, generating total gross&#13;proceeds of $9,225,000. A total of $9,000,000 of the net proceeds were deposited in the Trust Account, bringing the aggregate proceeds&#13;held in the Trust Account to $69,000,000.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;At the closing of the Initial&#13;Public Offering, the Company issued EarlyBirdCapital, Inc. (&amp;#34;EarlyBirdCapital&amp;#34;) and its designees 120,000 shares of common&#13;stock (the &amp;#8220;Representative Shares&amp;#8221;). On November 29, 2017, the Company issued an additional 18,000 Representative Shares&#13;for no consideration (see Note 9).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;Transaction costs amounted&#13;to $2,172,419, consisting of $1,725,000 of underwriting fees and $447,419 of Initial Public Offering costs.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;The Company&amp;#8217;s management&#13;has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and Private Placement&#13;Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination.&#13;The Company&amp;#8217;s initial Business Combination must be with one or more target businesses that together have a fair market value&#13;equal to at least 80% of the balance in the Trust Account (excluding taxes payable on income earned on the Trust Account) at the&#13;time of the signing an agreement to enter into a Business Combination. The Company will only complete a Business Combination if&#13;the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise&#13;acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the&#13;Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;The Company will provide&#13;its stockholders with the opportunity to redeem all or a portion of their shares included in the Units sold in the Initial Public&#13;Offering (the &amp;#8220;Public Shares&amp;#8221;) upon the completion of a Business Combination either (i) in connection with a stockholder&#13;meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will&#13;seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion.&#13;The stockholders will be entitled to redeem their shares for a pro rata portion of the amount then on deposit in the Trust Account&#13;($10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the&#13;Company to pay its franchise and income tax obligations). There will be no redemption rights upon the completion of a Business&#13;Combination with respect to the Company&amp;#8217;s warrants.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;The Company will proceed&#13;with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business&#13;Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the&#13;Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for&#13;business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation, conduct the&#13;redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (the &amp;#8220;SEC&amp;#8221;), and file tender&#13;offer documents with the SEC prior to completing a Business Combination. If, however, a stockholder approval of the transaction&#13;is required by law, or the Company decides to obtain stockholder approval for business or other legal reasons, the Company will&#13;offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer&#13;rules. If the Company seeks stockholder approval in connection with a Business Combination, the Company&amp;#8217;s Sponsor, officers&#13;and directors (the &amp;#8220;Initial Stockholders&amp;#8221;) have agreed (a) to vote their Founder&amp;#8217;s Shares (as defined in Note&#13;5), Placement Shares (as defined in Note 5) and any Public Shares held by them in favor of approving a Business Combination and&#13;(b) not to convert any Founder&amp;#8217;s Shares, Placement Shares and any Public Shares held by them in connection with a stockholder&#13;vote to approve a Business Combination or sell any such shares to the Company in a tender offer in connection with a Business Combination.&#13;Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against&#13;the proposed transaction.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;The Company initially had&#13;until November 22, 2018 to complete a Business Combination. However, if the Company anticipated that it would not be able to consummate&#13;a Business Combination by November 22, 2018, the Company could extend the period of time to consummate a Business Combination up&#13;to two times, each by an additional three months. Pursuant to the terms of the Company's Amended and Restated Certificate of Incorporation&#13;and the trust agreement entered into between the Company and Continental Stock Transfer &amp;#38; Trust Company on November 20, 2017,&#13;in order to extend the time available for the Company to consummate a Business Combination, the Sponsor or its affiliates or designees&#13;must deposit into the Trust Account $690,000 ($0.10 per share) for each three month extension, up to an aggregate of $1,380,000,&#13;or $0.20 per share, if the Company extends for the full six months, on or prior to the date of the applicable deadline.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;On November 20, 2018, the&#13;period of time for the Company to consummate a Business Combination was extended for an additional three-month period ending on&#13;February 22, 2019, and, accordingly, $690,000 was deposited into the Trust Account. On February 21, 2019, the Company further extended&#13;the time required to consummate a Business Combination to May 22, 2019 and deposited an additional $690,000 into the Trust Account.&#13;The deposits were funded by non-interest bearing unsecured promissory notes from BRAC Lending Group LLC, an affiliate of the underwriter&#13;(&amp;#8220;BRAC&amp;#8221;) (see Note 7). The notes are repayable upon the consummation of a Business Combination (see Note 6).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;On May 21, 2019, the Company&amp;#8217;s&#13;stockholders approved an amendment to its Amended and Restated Certificate of Incorporation to extend the period of time for which&#13;the Company was required to consummate a Business Combination to August 22, 2019. The number of shares of common stock presented&#13;for redemption in connection with the extension was 2,119,772. The Company paid cash in the aggregate amount of $22,099,233, or&#13;approximately $10.43 per share, to redeeming stockholders. The Company agreed to deposit, or cause to be deposited on its behalf,&#13;into the Trust Account $0.02 for each public share outstanding for each 30-day extension period utilized through August 22, 2019.&#13;In connection with this extension, the Company deposited an aggregate of $286,814 into the Trust Account,&amp;#160;of which $280,000&#13;was contributed to the Trust Account by a third party and is not required to be repaid by the Company. Accordingly, the Company&#13;has recorded this amount as a credit to additional paid in capital in the accompanying statements of stockholders&amp;#8217; equity.&#13;In order to pay for part of the third extension payment, the Company issued an unsecured promissory note (the &amp;#8220;Second Note&amp;#8221;)&#13;in favor of BRAC, in the original principal amount of $6,814 (see Note 7).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;On August 21, 2019, the&#13;Company stockholders approved an amendment to the Company&amp;#8217;s Amended and Restated Certificate of Incorporation to extend the&#13;period of time for which the Company is required to consummate a Business Combination (the &amp;#8220;Extension&amp;#8221;) from August&#13;22, 2019 to November 22, 2019. The number of shares of common stock presented for redemption in connection with the Extension was&#13;846,888. The Company paid cash in the aggregate amount of $8,891,378, or approximately $10.50 per share, to redeeming stockholders.&#13;The Company agreed to deposit, or cause to be deposited on its behalf, into the Trust Account $0.02 for each public share outstanding&#13;for each 30-day extension period utilized through the Extension. In connection with this extension, the Company deposited an aggregate&#13;of $236,000 into the Trust Account to fund this extension payment, which amount was loaned to the Company by AZ Property Partners,&#13;LLC (&amp;#8220;AZ Property Partners&amp;#8221;), an entity majority owned and controlled by Richard Ackerman, the Company's Chairman,&#13;President and Chief Executive Officer, and BRAC (see Note 7).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;On November 21, 2019, the&#13;Company's stockholders approved an amendment to the Company's Amended and Restated Certificate of Incorporation to extend the period&#13;of time for which the Company is required to consummate a Business Combination (the &amp;#8220;Second Extension&amp;#8221;) from November&#13;22, 2019 to March 23, 2020. The number of shares of common stock presented for redemption in connection with the Second Extension&#13;was 919,091. The Company paid cash in the aggregate amount of $9,736,077, or approximately $10.59 per share, to redeeming stockholders.&#13;The Company agreed to deposit, or cause to be deposited on its behalf, into the Trust Account $0.02 for each public share outstanding&#13;for each 30-day extension period utilized through the Second Extension. In connection with this extension, the Company deposited&#13;an aggregate of $60,285 into the Trust Account to fund the first thirty-day extension through December 22, 2019, which amount was&#13;loaned to the Company by AZ Property Partners and BRAC (see Note 7). In January and February 2020, AZ Property Partners and BRAC&#13;loaned the Company an additional aggregate amount of $90,427 each to pay for the extension through March 23, 2020, which was deposited&#13;into the Trust Account.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;On March 23, 2020, the&#13;Company's stockholders approved an amendment to the Amended and Restated Certificate of Incorporation to extend the period of time&#13;for which the Company is required to consummate a Business Combination (the &amp;#8220;Third Extension&amp;#8221;) from March 23, 2020&#13;to July 23, 2020. The number of shares of common stock presented for redemption in connection with the Third Extension was 2,433,721.&#13;The Company paid cash in the aggregate amount of $25,997,965, or approximately $10.68 per share, to redeeming stockholders. The&#13;Company agreed to deposit, or cause to be deposited on its behalf, into the Trust Account $0.02 for each public share outstanding&#13;for each 30-day extension period utilized through the Third Extension. Notwithstanding the foregoing, if the volume weighted average&#13;price of the Company's common stock during the 10-day trading period ending on the 3rd day prior to the end of any applicable monthly&#13;period was equal to or greater than $11.00 and the trading volume during the 10-day trading period exceeded 100,000 shares, the&#13;obligation to make any particular deposit would terminate with respect to the immediately following monthly period (but not with&#13;respect to any other future monthly period). In connection with this extension, the Company deposited an aggregate of $34,858 into&#13;the Trust Account to fund the extension through July 23, 2020, of which $17,429 was loaned to the Company by each of AZ Property&#13;Partners and BRAC.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;On July 23, 2020, the Company's&#13;stockholders approved an amendment to the Amended and Restated Certificate of Incorporation to extend the period of time for which&#13;the Company is required to consummate a Business Combination (the &amp;#8220;Fourth Extension&amp;#8221;) from July 23, 2020 to December&#13;23, 2020. The number of shares of common stock presented for redemption in connection with the Fourth Extension was 27,786. The&#13;Company paid cash in amount of $299,253, or approximately $10.77 per share, to redeeming stockholders. The Company agreed to deposit,&#13;or cause to be deposited on its behalf, into the Trust Account $0.02 for each public share outstanding for each 30-day extension&#13;period utilized through the Fourth Extension. In connection with this extension, as of November 13, 2020, the Company deposited&#13;an aggregate of $44,219 into the Trust Account, of which $22,110 was deposited as of September 30, 2020, to fund the extension&#13;through November 23, 2020, which amounts were loaned to the Company by AZ Property Partners and BRAC. Notwithstanding the foregoing,&#13;if the volume weighted average price of the Company's common stock during the 10-day trading period ending on the 3rd day prior&#13;to the end of any applicable monthly period is equal to or greater than $11.00 and the trading volume during the 10-day trading&#13;period exceeds 100,000 shares, the obligation to make any particular deposit would terminate with respect to the immediately following&#13;monthly period (but not with respect to any other future monthly period).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;On December 18, 2020, the&#13;Company held a special meeting pursuant to which the Company&amp;#8217;s stockholders approved an amendment to the Amended and Restated&#13;Certificate of Incorporation to extend the period of time for which the Company is required to consummate a Business Combination&#13;(the &amp;#8220;Fifth Extension&amp;#8221;) from December 23, 2020 to April 23, 2021 (the &amp;#8220;Extended Date&amp;#8221;). In connection with&#13;this extension, no stockholders elected to redeem their shares of common stock.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;If the Company is unable&#13;to complete a Business Combination by the Extended Date, the Company will (i) cease all operations except for the purpose of winding&#13;up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem 100% of the outstanding Public&#13;Shares, at a per share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest&#13;earned (net of taxes payable), divided by the number of then outstanding Public Shares, which redemption will completely extinguish&#13;public stockholders&amp;#8217; rights as stockholders (including the right to receive further liquidation distributions, if any), subject&#13;to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining&#13;stockholders and the Company&amp;#8217;s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution&#13;of the Company, subject in each case to its obligations to provide for claims of creditors and the requirements of applicable law.&#13;In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution (including&#13;Trust Account assets) will be less than the $10.00 per Unit in the Initial Public Offering.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;The Initial Stockholders&#13;have agreed to (i) waive their redemption rights with respect to Founder Shares, Placement Shares and any Public Shares they may&#13;acquire during or after the Initial Public Offering in connection with the consummation of a Business Combination, (ii) to waive&#13;their rights to liquidating distributions from the Trust Account with respect to their Founder&amp;#8217;s Shares and Placement Shares&#13;if the Company fails to consummate a Business Combination by the Extended Date and (iii) not to propose an amendment to the Company&amp;#8217;s&#13;Amended and Restated Certificate of Incorporation that would affect the substance or timing of the Company&amp;#8217;s obligation to&#13;redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public&#13;stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment. However, the Initial Stockholders&#13;will be entitled to liquidating distributions with respect to any Public Shares acquired if the Company fails to consummate a Business&#13;Combination or liquidates by Extended Date.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;In order to protect the&#13;amounts held in the Trust Account, A/Z Property Partners, has agreed that it will be liable to ensure that the proceeds in the&#13;Trust Account are not reduced below $10.00 per share by the claims of target businesses or claims of vendors or other entities&#13;that are owed money by the Company for services rendered or contracted for or products sold to the Company. Additionally, the agreement&#13;entered into by AZ Property Partners specifically provides for two exceptions to the indemnity it has given: it will have no liability&#13;(1) as to any claimed amounts owed to a target business or vendor or other entity who has executed an agreement with the Company&#13;waiving any right, title, interest or claim of any kind they may have in or to any monies held in the Trust Account, or (2) as&#13;to any claims for indemnification by the underwriters against certain liabilities, including liabilities under the Securities Act&#13;of 1933, as amended (the &amp;#8220;Securities Act&amp;#8221;). The Company will seek to reduce the possibility that AZ Property Partners&#13;will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective&#13;target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right,&#13;title, interest or claim of any kind in or to monies held in the Trust Account.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&lt;b&gt;NASDAQ Notifications&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;On January 7, 2019, the&#13;Company received a notice from the staff of the Listing Qualifications Department of Nasdaq (the &amp;#8220;Staff&amp;#8221;) stating that&#13;the Company was no longer in compliance with Nasdaq Listing Rule 5620(a) for continued listing due to its failure to hold an annual&#13;meeting of stockholders within twelve months of the end of the Company&amp;#8217;s fiscal year ended December 31, 2017. The Company&#13;submitted a plan of compliance with Nasdaq and Nasdaq granted the Company an extension until May 22, 2019 to regain compliance&#13;with the rule by holding an annual meeting of stockholders. The Company held its annual meeting of stockholders on May 21, 2019&#13;and, accordingly, the Staff determined that the Company was in compliance with Nasdaq Listing Rule 5620(a) for continued listing&#13;and the matter was closed.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;On August 9, 2019, the&#13;Company received a notice from the Staff stating that the Company was no longer in compliance with Nasdaq Listing Rule 5550(a)(3)&#13;for continued listing due to its failure to maintain a minimum of 300 public holders (the &amp;#8220;Rule&amp;#8221;). The Company had&#13;until September 23, 2019 to provide Nasdaq with a specific plan to achieve and sustain compliance with the listing requirement.&#13;The notice is a notification of deficiency, not of imminent delisting, and had no current effect on the listing or trading of the&#13;Company's securities on Nasdaq.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;On September 23, 2019 and&#13;October 28, 2019, the Company submitted a plan to regain compliance with Nasdaq and requested an extension through February 5,&#13;2020. On October 28, 2019, Nasdaq requested additional information regarding the Company's compliance plan, to which the Company&#13;responded on November 8, 2019. On February 11, 2020, the Company received a notice from the Staff stating that, based upon the&#13;Company&amp;#8217;s non-compliance with the Rule, the Staff had determined to delist the Company&amp;#8217;s common stock from Nasdaq unless&#13;the Company timely requests a hearing before the Nasdaq Hearings Panel (the &amp;#8220;Panel&amp;#8220;). The Company was also notified&#13;that as a result of Nasdaq&amp;#8217;s determination to delist the Company&amp;#8217;s common stock, the Company&amp;#8217;s warrants and rights&#13;no longer comply with Nasdaq Listing Rule 5560(a), which requires the underlying securities of such exercisable securities to remain&#13;listed on Nasdaq, and the Company&amp;#8217;s Units no longer comply with Nasdaq Listing Rule 5225(b)(1)(A), which requires all component&#13;parts of units to meet the requirements for initial and continued listing, and the Company&amp;#8217;s units, warrants and rights are&#13;now subject to delisting. The Company requested a hearing, which request automatically stayed any further action by the Staff pending&#13;the ultimate conclusion of the hearing process.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;On March 25, 2020, the&#13;Company received formal notice from Nasdaq indicating that the Staff had granted the Company&amp;#8217;s request for continued listing&#13;on Nasdaq. The decision followed the Company&amp;#8217;s hearing before the Panel, which took place on March 19, 2020. The Company&amp;#8217;s&#13;continued listing is subject to the Company&amp;#8217;s satisfaction of a number of conditions, including, ultimately, completion of&#13;a Business Combination with an operating company by no later than August 10, 2020, and the combined entity&amp;#8217;s compliance with&#13;all applicable criteria for initial listing on Nasdaq at the time of the merger. The Company failed to meet certain of the conditions&#13;contained in the extension grant and has submitted a modified extension request to the Staff.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;On August 10, 2020, the&#13;Company submitted a letter to Nasdaq indicating that it was in compliance with the Rule as of July 31, 2020 and, as a result, satisfies&#13;the minimum 300 public holder requirement and all other applicable criteria for continued listing on Nasdaq. Accordingly, the Company&#13;requested that the Staff render a formal determination to continue the listing of the Company&amp;#8217;s securities. On August 11,&#13;2020, the Company received a formal notice from Nasdaq notifying the Company that it regained compliance with the minimum 300 public&#13;holder requirements under Nasdaq rules and that the Panel had determined to continue the listing of the Company's securities on&#13;Nasdaq and close the matter.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;On November 23, 2020, the&#13;Company received a notice from Nasdaq stating that, as of November 20, 2020, the Company was not in compliance with Listing Rule&#13;IM-5101-2 (the &amp;#8220;Rule&amp;#8221;), which requires that a special purpose acquisition company complete one or more business combinations&#13;within 36 months of the effectiveness of the registration statement filed in connection with its initial public offering. Since&#13;the Company&amp;#8217;s registration statement became effective on November 20, 2017, it was required to complete an initial business&#13;combination by no later than November 20, 2020. The Rule also provides that failure to comply with this requirement will result&#13;in the Listing Qualifications Department issuing a Staff Delisting Determination under Rule 5810 to delist the Company&amp;#8217;s&#13;securities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&lt;b&gt;Liquidity&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;As of December 31, 2020,&#13;the Company had $466 in its operating bank account, $5,967,947 in cash and marketable securities held in the Trust Account to be&#13;used for a Business Combination or to repurchase or convert stock in connection therewith and an adjusted working capital deficit&#13;of $609,509, which excludes prepaid income taxes of $51,642 and prepaid franchise taxes of $30,350, which have been paid from amounts&#13;in the Trust Account. As of December 31, 2020, approximately $138,764 of the amount on deposit in the Trust Account represented&#13;interest income, which is available to pay the Company&amp;#8217;s tax obligations. To date, the Company has withdrawn $716,788 of&#13;interest from the Trust Account in order to pay the Company&amp;#8217;s franchise and income taxes, of which $161,430 was withdrawn&#13;during the year ended December 31, 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;On November 17, 2018, the&#13;Company entered into an agreement (the &amp;#8220;Agreement&amp;#8221;) with the Sponsor and BRAC, pursuant to which the Sponsor agreed&#13;to be responsible for all liabilities of the Company as of November 17, 2018 and to loan the Company the funds necessary to pay&#13;the expenses of the Company other than Business Combination expenses through the closing of a Business Combination when and as&#13;needed. If a Business Combination is not consummated, all outstanding loans made by the Sponsor will be forgiven (see Note 7).&#13;In addition, BRAC agreed to loan the Company all funds necessary to pay expenses incurred in connection with and in order to consummate&#13;a business combination (the &amp;#8220;Business Combination Expenses&amp;#8221;) and such loans will be added to the Initial Notes (as&#13;defined in Note 7). If the Company does not consummate a Business Combination, all outstanding loans under the Notes will be forgiven,&#13;except to the extent of any funds held outside of the Trust Account after paying all other fees and expenses of the Company incurred&#13;prior to the date of such failure to consummate a Business Combination (see Note 7).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;The Company may raise additional&#13;capital through loans or additional investments from the Sponsor or its stockholders, officers, directors, or third parties. Other&#13;than as described above, the Company&amp;#8217;s officers and directors and the Sponsor may, but are not obligated to, loan the Company&#13;funds, from time to time, in whatever amount they deem reasonable in their sole discretion, to meet the Company&amp;#8217;s working&#13;capital needs.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;The Company&#13;does not believe it will need to raise additional funds in order to meet expenditures required for operating its business.&#13;Neither the Sponsor, nor any of the stockholders, officers or directors, or third parties are under any obligation to advance&#13;funds to, or invest in, the Company, except as discussed above. Accordingly, the Company may not be able to obtain additional&#13;financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve&#13;liquidity, which could include, but not necessarily be limited to suspending the pursuit of a potential transaction. The&#13;Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all.&#13;Even if the Company can obtain sufficient financing or raise additional capital, it only has until April 23, 2021 (or as may&#13;be extended) to consummate a Business Combination. There is no assurance that the Company will be able to do so prior to&#13;April 23, 2021, or as may be extended by shareholder vote.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&lt;b&gt;&lt;i&gt;Risks and Uncertainties&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;Management continues to&#13;evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a&#13;negative effect on the Company's financial position, results of its operations and/or search for a target company, the specific&#13;impact is not readily determinable as of the date of these consolidated financial statements. The financial statements do not include&#13;any adjustments that might result from the outcome of this uncertainty.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;&amp;#160;&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Basis of Presentation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 80pt; text-align: justify; text-indent: 40pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;The accompanying consolidated&#13;financial statements are presented in conformity with accounting principles generally accepted in the United States of America&#13;(&amp;#8220;GAAP&amp;#8221;) and pursuant to the rules and regulations of the SEC.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&lt;b&gt;&lt;i&gt;Principles of Consolidation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;The accompanying consolidated&#13;financial statements include the accounts of the Company and its majority owned subsidiary where the Company has the ability to&#13;exercise control. All significant intercompany balances and transactions have been eliminated in consolidation. Activities in relation&#13;to the noncontrolling interest are not considered to be significant and are, therefore, not presented in the accompanying consolidated&#13;financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Emerging Growth Company&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;The Company is an &amp;#8220;emerging&#13;growth company,&amp;#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act&#13;of 2012 (the &amp;#8220;JOBS Act&amp;#8221;), and it may take advantage of certain exemptions from various reporting requirements that&#13;are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required&#13;to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding&#13;executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding&#13;advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;Further, Section 102(b)(1)&#13;of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards&#13;until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not&#13;have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting&#13;standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements&#13;that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt&#13;out of such extended transition period which means that when a standard is issued or revised and it has different application dates&#13;for public or private companies, the Company, as an emerging growth company, will adopt the new or revised standard at the time&#13;private companies adopt the new or revised standard. This may make comparison of the Company&amp;#8217;s consolidated financial statements&#13;with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using&#13;the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Use of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;The preparation of consolidated&#13;financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts&#13;of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported&#13;amounts of revenues and expenses during the reporting period.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 60pt"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;Making estimates requires&#13;management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition,&#13;situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating&#13;its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could&#13;differ significantly from the Company&amp;#8217;s estimates.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Cash and Cash Equivalents&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;The Company considers all&#13;short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did&#13;not have any cash equivalents as of December 31, 2020 and 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Cash and Marketable Securities Held in&#13;Trust Account&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;At December 31, 2020 and&#13;2019, the assets held in the Trust Account were held in money market funds, which are invested in U.S. Treasury securities. Through&#13;December 31, 2020, the Company has withdrawn $716,788 of interest from the Trust Account in order to pay its franchise and income&#13;taxes, of which $161,430 was withdrawn during the year ended December 31, 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Warrant Liabilities&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 40pt; text-align: justify"&gt;The Company accounts for warrants as either&#13;equity-classified or liability-classified instruments based on an assessment of the warrant&amp;#8217;s specific terms and applicable&#13;authoritative guidance in Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;) Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;)&#13;480, Distinguishing Liabilities from Equity (&amp;#8220;ASC 480&amp;#8221;) and ASC 815,&amp;#160;Derivatives and Hedging&amp;#160;(&amp;#8220;ASC&#13;815&amp;#8221;). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the&#13;definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification&#13;under ASC 815, including whether the warrants are indexed to the Company&amp;#8217;s own common shares and whether the warrant holders&#13;could potentially require &amp;#8220;net cash settlement&amp;#8221; in a circumstance outside of the Company&amp;#8217;s control, among other&#13;conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time&#13;of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 40pt; text-align: justify"&gt;For issued or modified warrants that meet all&#13;of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital&#13;at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants&#13;are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes&#13;in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. The fair&#13;value of the Private Placement Warrants was estimated using a Black-Scholes valuation approach (see Note 12).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Fair Value of Financial Instruments&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 40pt; text-align: justify"&gt;The Company applies ASC 820, &lt;i&gt;Fair Value Measurement&lt;/i&gt;&#13;(&amp;#34;ASC 820&amp;#34;), which establishes framework for measuring fair value and clarifies the definition of fair value within that&#13;framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer&#13;a liability in the Company&amp;#8217;s principal or most advantageous market in an orderly transaction between market participants&#13;on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable&#13;inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market&#13;participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent&#13;of the reporting entity. Unobservable inputs reflect the entity&amp;#8217;s own assumptions based on market data and the entity&amp;#8217;s&#13;judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based&#13;on the best information available in the circumstances.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 40pt; text-align: justify"&gt;The valuation hierarchy is composed of three&#13;levels. The classification within the valuation hierarchy is based on the lowest level of input that is significant to the fair&#13;value measurement. The levels within the valuation hierarchy are described below:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Level 1 - Assets and liabilities with unadjusted,&#13;quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices&#13;in active markets for identical assets or liabilities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Level 2 - Inputs to the fair value measurement&#13;are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect&#13;observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Level 3 - Inputs to the fair value measurement&#13;are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the&#13;assets or liabilities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;The fair value of&#13;the Company&amp;#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &amp;#8220;Fair Value Measurement,&amp;#8221;&#13;approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their short-te&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;rm&#13;nature.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 40pt; text-align: justify"&gt;See Note 12 for additional information on assets&#13;and liabilities measured at fair value.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Common Stock Subject to Possible Redemption&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;The Company accounts for&#13;its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;)&#13;Topic 480 &amp;#8220;Distinguishing Liabilities from Equity.&amp;#8221; Common stock subject to mandatory redemption is classified as a&#13;liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features&#13;redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events&#13;not solely within the Company&amp;#8217;s control) is classified as temporary equity. At all other times, common stock is classified&#13;as stockholders&amp;#8217; equity. The Company&amp;#8217;s common stock features certain redemption rights that are considered to be outside&#13;of the Company&amp;#8217;s control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible&#13;redemption is presented at redemption value as temporary equity, outside of the stockholders&amp;#8217; equity section of the Company&amp;#8217;s&#13;balance sheets. At December 31, 2020, there are no shares of common stock subject to possible redemption.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Income Taxes&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;The Company complies with&#13;the accounting and reporting requirements of ASC Topic 740 &amp;#8220;Income Taxes,&amp;#8221; which requires an asset and liability approach&#13;to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences&#13;between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts,&#13;based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation&#13;allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;ASC Topic 740 prescribes&#13;a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken&#13;or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be&#13;sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized&#13;tax benefits as income tax expense. As of December 31, 2020 and 2019, there were no unrecognized tax benefits and no amounts accrued&#13;for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments,&#13;accruals or material deviation from its position.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;The Company may be subject&#13;to potential examination by federal, state and city taxing authorities in the areas of income taxes. These potential examinations&#13;may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance&#13;with federal, state and city tax laws. The Company&amp;#8217;s management does not expect that the total amount of unrecognized tax&#13;benefits will materially change over the next twelve months.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;On March 27, 2020, the&#13;CARES Act was enacted in response to COVID-19 pandemic. Under ASC 740, the effects of changes in tax rates and laws are recognized&#13;in the period which the new legislation is enacted. The CARES Act made various tax law changes including among other things (i)&#13;increasing the limitation under Section 163(j) of the Internal Revenue Code of 1986, as amended (the &amp;#8220;IRC&amp;#8221;) for 2019&#13;and 2020 to permit additional expensing of interest (ii) enacting a technical correction so that qualified improvement property&#13;can be immediately expensed under IRC Section 168(k), (iii) making modifications to the federal net operating loss rules including&#13;permitting federal net operating losses incurred in 2018, 2019, and 2020 to be carried back to the five preceding taxable years&#13;in order to generate a refund of previously paid income taxes and (iv) enhancing the recoverability of alternative minimum tax&#13;credits. Given the Company&amp;#8217;s full valuation allowance position, the CARES Act did not have&#13;an impact on the financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Net Income (Loss) Per Common Share&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 40pt; text-align: justify"&gt;Net income (loss) per share is computed by dividing&#13;net income by the weighted-average number of shares of common stock outstanding during the period, excluding shares of common stock&#13;subject to forfeiture. The Company has not considered the effect of (1) warrants sold in the Initial Public Offering and private&#13;placement to purchase 3,586,250 shares of common stock, (2) rights sold in the Initial Public Offering and private placement that&#13;convert into 717,250 shares of common stock and (3) 600,000 shares of common stock, warrants to purchase 300,000 shares of common&#13;stock and rights that convert into 60,000 shares of common stock in the unit purchase option sold to the underwriter, in the calculation&#13;of diluted (loss) income per share, since the exercise of the warrants are contingent upon the occurrence of future events and&#13;the inclusion of such warrants would be anti-dilutive.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 40pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0.7pt 0 0pt; text-indent: 40pt; text-align: justify"&gt;The Company&amp;#8217;s consolidated statements&#13;of operations include a presentation of income (loss) per share for common shares subject to possible redemption in a manner similar&#13;to the two-class method of income (loss) per share. Net income (loss) per common share, basic and diluted, for Common stock subject&#13;to possible redemption is calculated by dividing the proportionate share of income or loss on marketable securities held by the&#13;Trust Account, net of applicable franchise and income taxes, by the weighted average number of shares of Common stock subject to&#13;possible redemption outstanding since original issuance.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0.7pt 0 0pt; text-indent: 40pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0.7pt 0 0pt; text-indent: 40pt; text-align: justify"&gt;Net income (loss) per share, basic&#13;and diluted, for non-redeemable common stock is calculated by dividing the net income (loss), adjusted for income or loss on marketable&#13;securities attributable to Common stock subject to possible redemption, by the weighted average number of non-redeemable common&#13;stock outstanding for the period.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0.7pt 0 0pt; text-indent: 40pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0.7pt 0 0pt; text-indent: 40pt; text-align: justify"&gt;Non-redeemable common stock includes&#13;Founder Shares and non-redeemable shares of common stock as these shares do not have any redemption features. Non-redeemable common&#13;stock participates in the income or loss on marketable securities based on non-redeemable shares&amp;#8217; proportionate interest.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0.7pt 0 0pt; text-indent: 40pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 40pt; text-align: justify"&gt;The following table reflects the calculation&#13;of basic and diluted net income (loss) per common share (in dollars, except per share amounts):&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="7" style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: center"&gt;Year Ended December 31,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-style: italic; text-align: left"&gt;Common stock subject to possible redemption&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;Numerator: Earnings allocable to Common stock subject to possible redemption&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 0pt; width: 56%; font-size: 8pt; text-align: left; text-indent: 10pt"&gt;Interest earned on marketable securities held in Trust Account&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; width: 8%; font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; width: 1%; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; width: 12%; font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; width: 1%; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; width: 8%; font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; width: 1%; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; width: 12%; font-size: 8pt; text-align: right"&gt;922,211&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; width: 1%; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 0pt; font-size: 8pt; text-align: left; padding-bottom: 1pt; text-indent: 10pt"&gt;Less: interest available to be withdrawn for payment of taxes&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: right"&gt;(218,317&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 0pt; font-size: 8pt; text-align: left; padding-bottom: 2.5pt; text-indent: 30pt"&gt;Net income attributable&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;703,894&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;Denominator: Weighted Average Common stock subject to possible redemption&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted weighted average shares outstanding, Common stock subject to possible redemption&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;546,586&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;4,555,229&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted net income per share, Common stock subject to possible redemption&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;0.15&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-style: italic; text-align: left"&gt;Non-Redeemable Common Stock&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;Numerator: Net Loss minus Net Earnings&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 0pt; font-size: 8pt; text-align: left; text-indent: 10pt"&gt;Net loss&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: right"&gt;(1,089,510&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: right"&gt;(1,594&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 0pt; font-size: 8pt; text-align: left; padding-bottom: 1pt; text-indent: 10pt"&gt;Net income allocable to Common stock subject to possible redemption&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 0pt; font-size: 8pt; text-align: left; padding-bottom: 2.5pt; text-indent: 30pt"&gt;Non-Redeemable Net Loss&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;(1,089,510&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;(1,594&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;Denominator: Weighted Average Non-redeemable common stock&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted weighted average shares outstanding, Non-redeemable common stock&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;2,736,258&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;2,783,021&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted net loss per share, Non-redeemable common stock&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;(0.40&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;(0.11&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&lt;b&gt;&amp;#160;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Concentration of Credit Risk&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;Financial instruments&#13;that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which,&#13;at times may exceed the Federal depository insurance coverage limit of $250,000. The Company has not experienced losses on this&#13;account and management believes the Company is not exposed to significant risks on such account.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Derivative&#13;Financial Instruments&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 40pt; text-align: justify"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;The&#13;Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify&#13;as embedded derivatives in accordance with ASC Topic 815, &amp;#8220;Derivatives and Hedging&amp;#8221;. For derivative financial instruments&#13;that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and&#13;is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification&#13;of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at&#13;the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on&#13;whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Recently&#13;I&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;b&gt;&lt;i&gt;ssued Accounting Standards&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;Management does not believe&#13;that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the&#13;Company&amp;#8217;s consolidated financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <BRPAU:InitialPublicOfferingDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;Pursuant to the Initial&#13;Public Offering, the Company sold 6,900,000 Units at a purchase price of $10.00 per Unit, which includes the full exercise by the&#13;underwriters of their over-allotment option of 900,000 Units at $10.00 per Unit. Each Unit consists of one share of common stock,&#13;one Public Right and one Public Warrant. Each Public Right will convert into one-tenth (1/10) of one share of common stock upon&#13;consummation of a Business Combination (see Note 9). Each whole Public Warrant entitles the holder to purchase one share of common&#13;stock at an exercise price of $11.50 per whole share (see Note 9).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;</BRPAU:InitialPublicOfferingDisclosureTextBlock>
    <BRPAU:PrivatePlacementDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;Simultaneously with the&#13;Initial Public Offering, the Sponsor purchased 250,000 Private Placement Units, at $10.00 per Private Placement Unit, for an aggregate&#13;purchase price of $2,500,000. On November 29, 2017, the Company consummated the sale of an additional 22,500 Private Placement&#13;Units at a price of $10.00 per unit, which were purchased by the Sponsor, generating gross proceeds of $225,000. Each Private Placement&#13;Unit consists of one share of common stock (&amp;#8220;Placement Share&amp;#8221;), one right (&amp;#8220;Placement Right&amp;#8221;) and one-half&#13;of one warrant (each, a &amp;#8220;Placement Warrant&amp;#8221;), each whole Placement Warrant exercisable to purchase one share of common&#13;stock at an exercise price of $11.50. The proceeds from the Private Placement Units were added to the proceeds from the Initial&#13;Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period,&#13;the proceeds from the sale of the Private Placement Units will be used to fund the redemption of the Public Shares (subject to&#13;the requirements of applicable law), and the Placement Rights and the Placement Warrants will expire worthless.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;The Private Placement Units&#13;are identical to the Units sold in the Initial Public Offering except that the Placement Warrants (i) are not redeemable by the&#13;Company and (ii) may be exercised for cash or on a cashless basis, so long as they are held by the initial purchaser or any of&#13;its permitted transferees. In addition, the Private Placement Units and their component securities may not be transferable, assignable&#13;or salable until after the consummation of a Business Combination, subject to certain limited exceptions. If the Placement Warrants&#13;are held by someone other than the initial purchasers or their permitted transferees, the Placement Warrants will be redeemable&#13;by the Company and exercisable by such holders on the same basis as the Public Warrants.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</BRPAU:PrivatePlacementDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"&gt;&lt;font style="color: Black"&gt;&lt;b&gt;&lt;i&gt;Founder&#13;Shares&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt"&gt;&lt;font style="color: Black"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;&lt;font style="color: Black"&gt;In&#13;September 2017, the Company issued an aggregate of 1,437,500 shares of common stock to the Sponsor (the &amp;#8220;Founder Shares&amp;#8221;)&#13;for an aggregate purchase price of $25,000. On November 20, 2017, the Company effectuated a 1.2-for-1 stock dividend of its common&#13;stock resulting in an aggregate of 1,725,000 Founder Shares outstanding. The Founder Shares included an aggregate of up to 225,000&#13;shares subject to forfeiture by the Sponsor to the extent that the underwriters&amp;#8217; over-allotment was not exercised in full&#13;or in part, so that the Initial Stockholders would own 20% of the Company&amp;#8217;s issued and outstanding shares after the Initial&#13;Public Offering (excluding the Private Placement Units and the Representative Shares (as defined in Note 9)). As a result of the&#13;underwriters&amp;#8217; election to fully exercise their over-allotment option, 225,000 Founder Shares are no longer subject to forfeiture.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt"&gt;&lt;font style="color: Black"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;&lt;font style="color: Black"&gt;The&#13;Initial Stockholders have agreed not to transfer, assign or sell any of the Founder&amp;#8217;s Shares until the earlier of (i) one&#13;year after the date of the consummation of a Business Combination, or (ii) with respect to 50% of the Founder Shares, the date&#13;on which the closing price of the Company&amp;#8217;s common stock equals or exceeds $12.50 per share (as adjusted for stock splits,&#13;stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after&#13;a Business Combination, or earlier, in each case, if subsequent to a Business Combination, the Company consummates a subsequent&#13;liquidation, merger, stock exchange, reorganization or other similar transaction which results in all of the Company&amp;#8217;s stockholders&#13;having the right to exchange their common stock for cash, securities or other property.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt"&gt;&lt;font style="color: Black"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"&gt;&lt;font style="color: Black"&gt;&lt;b&gt;&lt;i&gt;Related&#13;Party Loans&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt"&gt;&lt;font style="color: Black"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;&lt;font style="color: Black"&gt;In&#13;order to finance transaction costs in connection with a Business Combination, the Sponsor, an affiliate of the Sponsor, or the&#13;Company&amp;#8217;s officers and directors may, but are not obligated to, loan the Company funds from time to time or at any time,&#13;as may be required (&amp;#8220;Working Capital Loans&amp;#8221;). Each Working Capital Loan would be evidenced by a promissory note. The&#13;Working Capital Loans would either be paid upon consummation of a Business Combination, without interest, or, at the holder&amp;#8217;s&#13;discretion, up to $1,500,000 of the Working Capital Loans may be converted into units at a price of $10.00 per unit. The units&#13;would be identical to the Private Placement Units. In the event that a Business Combination does not close, the loans will be&#13;forgiven. There were no outstanding Working Capital Loans at December 31, 2020 and 2019.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;&lt;font style="color: Black"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;On November 17, 2018, the&#13;Company entered into an Extension Funding Agreement with the Sponsor and BRAC. Pursuant to the Extension Funding Agreement, the&#13;Sponsor transferred an aggregate of 1,500,000 Founders Shares to BRAC in exchange for the agreements set forth below and aggregate&#13;cash consideration of $1.00.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;Pursuant to the Extension&#13;Funding Agreement, the Sponsor agreed to extend the period of time the Company has to consummate a Business Combination up to two&#13;times for an aggregate of up to six months and BRAC agreed to loan the Company the funds necessary to obtain the extensions (the&#13;&amp;#8220;Extensions&amp;#8221;). On November 20, 2018 and February 21, 2019, the Company issued unsecured promissory notes (the &amp;#8220;Initial&#13;Notes&amp;#8221;) in favor of BRAC, in the original principal amount of $690,000 each (or an aggregate of $1,380,000), to provide the&#13;Company the funds necessary to obtain an aggregate of six-months of Extensions. Pursuant to the Extension Funding Agreement, BRAC&#13;has also agreed to loan the Company all funds necessary to pay expenses incurred in connection with and in order to consummate&#13;a Business Combination (the &amp;#8220;Business Combination Expenses&amp;#8221;) and such loans will be added to the Initial Notes.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;In connection with the&#13;stockholders&amp;#8217; approval of the extended date of August 22, 2019, the Company issued another unsecured promissory note (the&#13;&amp;#8220;Second Note&amp;#8221;) in favor of BRAC in order to pay for part of the third extension payment in the original principal amount&#13;of $6,814.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;On December 31, 2019, the&#13;Company issued an unsecured promissory note, as amended on March 31, 2020, June 30,2020 and September 30, 2020, (the &amp;#8220;Third&#13;Note&amp;#8221; and, together with the Initial Notes and the Second Note, the &amp;#8220;Extension Notes&amp;#8221;) in favor of BRAC in the&#13;aggregate principal amount of $317,547 in order to pay for part of the extension payments. Through December 31, 2020, BRAC loaned&#13;the Company an aggregate of $423,075, of which $141,299 was loaned during the year ended December 31, 2020 to pay for part of the&#13;extension payments through December 23, 2020 and $32,967 was loaned during the year ended December 31, 2020 to pay for extension&#13;related costs and $100,000 was loaned during the year ended December 31, 2020 for working capital purposes.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;If the Company does not&#13;consummate a Business Combination, all outstanding loans under the Extension Notes will be forgiven, except to the extent of any&#13;funds held outside of the Trust Account after paying all other fees and expenses of the Company incurred prior to the date of such&#13;failure to consummate a Business Combination.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;As of December 31, 2020,&#13;the outstanding balance under the Extension Notes amounted to an aggregate of approximately $1,809,889.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;The Sponsor has agreed&#13;to be responsible for all liabilities of the Company effective November 17, 2018, except for liabilities associated with the possible&#13;redemption of shares by the Company&amp;#8217;s shareholders, as described in the Company&amp;#8217;s Amended and Restated Certificate&#13;of Incorporation. The Sponsor has also agreed to loan the Company the funds necessary to pay the expenses of the Company other&#13;than the Business Combination Expenses through the closing of a Business Combination when and as needed in order for the Company&#13;to continue in operation (the &amp;#8220;Non-Business Combination Related Expenses&amp;#8221;). Upon consummation of a Business Combination,&#13;up to $200,000 of the Non-Business Combination Related Expenses will be repaid by the Company to the Sponsor provided that the&#13;Company has funds available to it sufficient to repay such expenses (the &amp;#8220;Cap&amp;#8221;) as well as to pay for all stockholder&#13;redemptions, all Business Combination Expenses, repayment of the Extension Notes, and any funds necessary for the working capital&#13;requirements of the Company following closing of the Business Combination. Any remaining amounts in excess of the Cap will be forgiven.&#13;On December 31, 2019, the Company issued an unsecured promissory note to the Sponsor, as amended on March 31, 2020, June 30, 2020&#13;and September 30, 2020, in the principal amount of approximately $862,148 to pay for Non-Business Combination Related Expenses&#13;incurred through December 31, 2020 and expenses incurred thereafter. If the Company does not consummate a Business Combination,&#13;all outstanding loans made by the Sponsor to cover the Non-Business Combination Related Expenses will be forgiven, except as set&#13;forth above. The Company repaid $35,000 of such loans during the year ended December 31, 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;Through December 31, 2020,&#13;AZ Property Partners loaned the Company an aggregate of $862,148, of which $141,299 was loaned during the year ended December 31,&#13;2020 to pay for part of the extension payments through December 23, 2020 and $339,708 was loaned during the year ended December&#13;31, 2020 to pay for Non-Business Combination Related Expenses.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;As of December 31, 2020,&#13;the outstanding balance under promissory note with AZ Property Partners amounted to $862,148.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Forgiveness of Debt&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;During the year ended December&#13;31, 2020, one of the Company&amp;#8217;s service providers forgave certain amounts due to them in connection with previously provided&#13;services. As a result, the Company recorded a forgiveness of debt in the amount of $352,071.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Registration Rights&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;Pursuant to a registration&#13;rights agreement entered into on November 20, 2017, the holders of the Company&amp;#8217;s common stock prior to the Initial Public&#13;Offering (the &amp;#8220;Founder Shares&amp;#8221;), Private Placement Units (and their underlying securities), the shares issued to EarlyBirdCapital&#13;at the closing of the Initial Public Offering (the &amp;#8220;Representative Shares&amp;#8221;) and any Units that may be issued upon conversion&#13;of the working capital loans (and their underlying securities) are entitled to registration rights. The holders of a majority of&#13;these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities.&#13;The holders of the majority of the Founder&amp;#8217;s Shares can elect to exercise these registration rights at any time commencing&#13;three months prior to the date on which these shares of common stock are to be released from escrow. The holders of a majority&#13;of the Private Placement Units or Units issued to the Sponsor, officers, directors or their affiliates in payment of working capital&#13;loans made to the Company (in each case, including the underlying securities) can elect to exercise these registration rights at&#13;any time after the Company consummates a Business Combination. In addition, the holders will have certain &amp;#8220;piggy-back&amp;#8221;&#13;registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights&#13;to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act of 1933, as amended&#13;(the &amp;#8220;Securities Act&amp;#8221;). Notwithstanding anything to the contrary, EarlyBirdCapital and its designees may participate&#13;in a &amp;#8220;piggy-back&amp;#8221; registration during the seven-year period beginning on the effective date of the registration statement.&#13;However, the registration rights agreement will provide that the Company will not permit any registration statement filed under&#13;the Securities Act to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred&#13;in connection with the filing of any such registration statements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Business Combination Marketing Agreement&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;The Company has engaged&#13;EarlyBirdCapital as an advisor in connection with a Business Combination to assist the Company in holding meetings with its stockholders&#13;to discuss a potential Business Combination and the target business&amp;#8217; attributes, introduce the Company to potential investors&#13;that are interested in purchasing securities, assist the Company in obtaining stockholder approval for the Business Combination&#13;and assist the Company with its press releases and public filings in connection with a Business Combination. The Company will pay&#13;EarlyBirdCapital a cash fee for such services upon the consummation of a Business Combination in an amount equal to 4.0% of the&#13;gross proceeds of the Initial Public Offering (exclusive of any applicable finders&amp;#8217; fees which might become payable). If&#13;a Business Combination is not consummated for any reason, no fee will be due or payable.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Merger Agreement&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;On December 13, 2020, the&#13;Company, NeuroRx and Merger Sub, entered into an Agreement and Plan of Merger (&amp;#8220;Merger Agreement&amp;#8221;). Pursuant to the&#13;Merger Agreement, Merger Sub will merge with and into NeuroRx, with NeuroRx surviving the merger (&amp;#8220;Merger&amp;#8221;). As a result&#13;of the Merger, and upon consummation of the Merger and the other transactions contemplated by the Merger Agreement (&amp;#8220;Transactions&amp;#8221;),&#13;NeuroRx will become a wholly-owned subsidiary of the Company, with the stockholders of NeuroRx becoming stockholders of the Company.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;Pursuant to the Merger&#13;Agreement, the aggregate consideration payable to the stockholders of NeuroRx at the effective time of the Merger (the &amp;#8220;Effective&#13;Time&amp;#8221;) will equal 50,000,000 shares (&amp;#8220;Closing Consideration&amp;#8221;) of the Company&amp;#8217;s common stock, par value&#13;$0.001 per share (&amp;#8220;Company Common Stock&amp;#8221;), plus the additional contingent right to receive the Earnout Shares and Earnout&#13;Cash (each as defined below). At the Effective Time, each outstanding share of NeuroRx common stock (including shares of NeuroRx&#13;common stock resulting from the conversion of NeuroRx preferred stock immediately prior to the Effective Time) will be converted&#13;into the right to receive a pro rata portion of the Closing Consideration and the contingent right to receive a pro rata portion&#13;of the Earnout Shares and Earnout Cash. Each option and warrant of NeuroRx that is outstanding and unexercised immediately prior&#13;to the Effective Time will be assumed by the Company and will represent the right to acquire an adjusted number of shares of the&#13;Company Common Stock at an adjusted exercise price, in each case, pursuant to the terms of the Merger Agreement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;As part of the aggregate&#13;consideration payable to NeuroRx&amp;#8217;s securityholders pursuant to the terms of the Merger Agreement, NeuroRx&amp;#8217;s securityholders&#13;(including option holders and warrant holders) who own NeuroRx securities immediately prior to the closing of the Transactions&#13;will have the contingent right to receive their pro rata portion of (i) an aggregate of 25,000,000 shares of the Company Common&#13;Stock (&amp;#8220;Earnout Shares&amp;#8221;) if, prior to December 31, 2022, the NeuroRx COVID-19 Drug receives emergency use authorization&#13;by the Food and Drug Administration (&amp;#8220;FDA&amp;#8221;) and NeuroRx submits and the FDA files for review a new drug application&#13;for the NeuroRx COVID-19 Drug (the occurrence of the foregoing, the &amp;#8220;Earnout Shares Milestone&amp;#8221;), and (ii) an aggregate&#13;of $100,000,000 in cash (&amp;#8220;Earnout Cash&amp;#8221;) upon the earlier to occur of (x) FDA approval of the NeuroRx COVID-19 Drug&#13;and the listing of the NeuroRx COVID-19 Drug in the FDA&amp;#8217;s &amp;#8220;Orange Book&amp;#8221; and (y) FDA approval of the NeuroRx Antidepressant&#13;Drug Regimen and the listing of the NeuroRx Antidepressant Drug Regimen in the FDA&amp;#8217;s &amp;#8220;Orange Book,&amp;#8221; in each case&#13;prior to December 31, 2022 (the occurrence of either of clauses (x) or (y), the &amp;#8220;Earnout Cash Milestone&amp;#8221;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;The Merger Agreement contains&#13;customary representations, warranties and covenants by the parties thereto and the closing is subject to certain conditions as&#13;further described in the Merger Agreement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;&lt;b&gt;&lt;i&gt;Preferred Stock&lt;/i&gt;&lt;/b&gt;&#13;&amp;#8212; The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.001 per share with such designation,&#13;rights and preferences as may be determined from time to time by the Company&amp;#8217;s Board of Directors. At December 31, 2020 and&#13;2019, there were no shares of preferred stock issued or outstanding.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;&lt;b&gt;&lt;i&gt;Common Stock&lt;/i&gt;&lt;/b&gt;&#13;&amp;#8212; The Company is authorized to issue 100,000,000 shares of common stock with a par value of $0.001 per share. Holders of&#13;the Company&amp;#8217;s common stock are entitled to one vote for each share. At December 31, 2020 and 2019, there were 2,688,242 and&#13;2,844,414 shares of common stock issued and outstanding, respectively (excluding -0- and 2,305,335 shares of common stock subject&#13;to possible redemption, respectively).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;&lt;b&gt;&lt;i&gt;Rights&lt;/i&gt;&lt;/b&gt; &amp;#8212;&#13;Each holder of a right will receive one-tenth (1/10) of one share of common stock upon consummation of a Business Combination,&#13;even if the holder of such right redeemed all shares held by it in connection with a Business Combination. No fractional shares&#13;will be issued upon conversion of the rights. No additional consideration will be required to be paid by a holder of rights in&#13;order to receive its additional shares upon consummation of a Business Combination, as the consideration related thereto has been&#13;included in the Unit purchase price paid for by investors in the Initial Public Offering. If the Company enters into a definitive&#13;agreement for a Business Combination in which the Company will not be the surviving entity, the definitive agreement will provide&#13;for the holders of rights to receive the same per share consideration the holders of the common stock will receive in the transaction&#13;on an as-converted into common stock basis and each holder of a right will be required to affirmatively convert its rights in order&#13;to receive 1/10 share underlying each right (without paying additional consideration). The shares issuable upon conversion of the&#13;rights will be freely tradable (except to the extent held by affiliates of the Company).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;If the Company is unable&#13;to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account,&#13;holders of rights will not receive any of such funds with respect to their rights, nor will they receive any distribution from&#13;the Company&amp;#8217;s assets held outside of the Trust Account with respect to such rights, and the rights will expire worthless.&#13;Further, there are no contractual penalties for failure to deliver securities to the holders of the rights upon consummation of&#13;a Business Combination. Additionally, in no event will the Company be required to net cash settle the rights. Accordingly, holders&#13;of the rights might not receive the shares of common stock underlying the rights.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Representative Shares&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;At the closing of the Initial&#13;Public Offering, the Company issued EarlyBirdCapital and its designees 120,000 Representative Shares. On November 29, 2017, the&#13;Company issued an additional 18,000 Representative Shares for no consideration. The Company accounted for the Representative Shares&#13;as an expense of the Initial Public Offering resulting in a charge directly to stockholders&amp;#8217; equity. The Company determined&#13;the fair value of Representative Shares to be $1,380,000 based upon the offering price of the Units of $10.00 per Unit. The underwriter&#13;has agreed not to transfer, assign or sell any such shares until the completion of a Business Combination. In addition, the underwriter&#13;and its designees have agreed (i) to waive their redemption rights with respect to such shares in connection with the completion&#13;of a Business Combination and (ii) to waive their rights to liquidating distributions from the Trust Account with respect to such&#13;shares if the Company fails to complete a Business Combination within the Combination Period.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Unit Purchase Option&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;On November 22, 2017, the&#13;Company sold to EarlyBirdCapital, for $100, an option to purchase up to 600,000 Units exercisable at $10.00 per Unit (or an aggregate&#13;exercise price of $6,000,000) commencing on the later of November 20, 2018 or the consummation of a Business Combination. The unit&#13;purchase option may be exercised for cash or on a cashless basis, at the holder&amp;#8217;s option, and expires five years from November&#13;20, 2017. The Units issuable upon exercise of this option are identical to those offered in the Initial Public Offering. The Company&#13;accounted for the unit purchase option, inclusive of the receipt of $100 cash payment, as an expense of the Initial Public Offering&#13;resulting in a charge directly to stockholders&amp;#8217; equity. The Company estimated the fair value of this unit purchase option&#13;to be $2,042,889 (or $3.40 per Unit) using the Black-Scholes option-pricing model. The fair value of the unit purchase option granted&#13;to the underwriters was estimated as of the date of grant using the following assumptions: (1) expected volatility of 35%, (2)&#13;risk-free interest rate of 2.05% and (3) expected life of five years. The option and such units purchased pursuant to the option,&#13;as well as the common stock underlying such units, the rights included in such units, the common stock that is issuable for the&#13;rights included in such units, the warrants included in such units, and the shares underlying such warrants, have been deemed compensation&#13;by FINRA and are therefore subject to a 180-day lock-up pursuant to Rule 5110(g)(1) of FINRA&amp;#8217;s NASDAQ Conduct Rules. Additionally,&#13;the option may not be sold, transferred, assigned, pledged or hypothecated for a one-year period (including the foregoing 180-day&#13;period) following the date of Initial Public Offering except to any underwriter and selected dealer participating in the Initial&#13;Public Offering and their bona fide officers or partners. The option grants to holders demand and &amp;#8220;piggy back&amp;#8221; rights&#13;for periods of five and seven years, respectively, from the effective date of the registration statement with respect to the registration&#13;under the Securities Act of the securities directly and indirectly issuable upon exercise of the option. The Company will bear&#13;all fees and expenses attendant to registering the securities, other than underwriting commissions which will be paid for by the&#13;holders themselves. The exercise price and number of units issuable upon exercise of the option may be adjusted in certain circumstances&#13;including in the event of a stock dividend, or the Company&amp;#8217;s recapitalization, reorganization, merger or consolidation. However,&#13;the option will not be adjusted for issuances of common stock at a price below its exercise price.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;&amp;#160;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 40pt"&gt;The Company&amp;#8217;s net deferred tax assets&#13;are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 60pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left; text-indent: 0pt"&gt;Deferred tax assets&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="width: 56%; font-size: 8pt; text-align: left; text-indent: 0pt; padding-left: 10pt"&gt;Net operating loss carryforward&lt;/td&gt;&lt;td style="width: 8%; font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 8pt; text-align: right"&gt;105,559&lt;/td&gt;&lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left; padding-bottom: 1pt; text-indent: 0pt; padding-left: 10pt"&gt;Unrealized gain on marketable securities&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left; text-indent: 0pt"&gt;Total deferred tax assets&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;105,559&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left; padding-bottom: 1pt; text-indent: 0pt"&gt;Valuation Allowance&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"&gt;(105,559&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left; padding-bottom: 2.5pt; text-indent: 0pt"&gt;Deferred tax assets, net valuation allowance&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 40pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;The income tax provision&#13;consists of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 8pt"&gt;Federal&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 56%; font-size: 8pt; text-indent: 0pt; padding-left: 10pt"&gt;Current&lt;/td&gt;&lt;td style="width: 8%; font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 8pt; text-align: right"&gt;17,841&lt;/td&gt;&lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 8pt; text-align: right"&gt;102,332&lt;/td&gt;&lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 8pt; text-indent: 0pt; padding-left: 10pt"&gt;Deferred&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;(87,480&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;2,936&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-indent: 0pt"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left; text-indent: 0pt"&gt;State and Local&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-size: 8pt; text-indent: 0pt; padding-left: 10pt"&gt;Current&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 8pt; text-indent: 0pt; padding-left: 10pt"&gt;Deferred&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;(18,079&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 10pt"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left; padding-bottom: 1pt; text-indent: 0pt"&gt;Change in valuation allowance&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"&gt;105,559&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"&gt;(21,062&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-indent: 0pt"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left; padding-bottom: 2.5pt; text-indent: 0pt"&gt;Income tax provision&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: right"&gt;17,841&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: right"&gt;84,206&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 60pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;As of December 31, 2020&#13;and 2019, the Company had $416,571 and $-0- of U.S. federal and state net operating loss carryovers available to offset future&#13;taxable income, respectively which carryforward indefinitely.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 40pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;In assessing the realization&#13;of the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax&#13;assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable&#13;income during the periods in which temporary differences representing net future deductible amounts become deductible. Management&#13;considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making&#13;this assessment. &lt;font style="color: #231F20"&gt;After consideration of all of the information available, management believes that&#13;significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full&#13;valuation allowance. For the year ended December 31, 2020 and 2019, the change in the valuation allowance was $105,559 and $21,062.&#13;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 40pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 40pt"&gt;A reconciliation of the federal income tax rate&#13;to the Company&amp;#8217;s effective tax rate is as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 60pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"&gt;December 31, 2020&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"&gt;December 31, 2019&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 56%; font-size: 8pt; text-align: left; text-indent: 0pt"&gt;Statutory federal income tax rate&lt;/td&gt;&lt;td style="width: 8%; font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 12%; font-size: 8pt; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 8%; font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 12%; font-size: 8pt; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left; text-indent: 0pt"&gt;State taxes, net of federal tax benefit&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;4.3&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;0.0&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-size: 8pt; text-indent: 0pt"&gt;True-ups&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;(1.7&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;)%&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;0.4&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 8pt; text-indent: 0pt"&gt;Change in FV of warrant liabilities&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;&amp;#160;(15.5&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;)%&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;&amp;#160;0.0&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left; padding-bottom: 1pt; text-indent: 0pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"&gt;(9.9&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;)%&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"&gt;(4.3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left; padding-bottom: 2.5pt; text-indent: 0pt"&gt;Income tax provision&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: right"&gt;(1.7&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 8pt; text-align: left"&gt;)%&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: right"&gt;17.1&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 8pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 60pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;The Company files income&#13;tax returns in the U.S. federal jurisdiction and is subject to examination by the various taxing authorities. The Company's tax&#13;returns since inception remain open to examination by the taxing authorities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;&amp;#160;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;The following table presents&#13;information about the Company&amp;#8217;s assets and liabilities that are measured at fair value on a recurring basis at December&#13;31, 2020 and 2019, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair&#13;value:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 20pt; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: justify"&gt;Description&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"&gt;Level&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"&gt;December&amp;#160;31,&lt;br /&gt; 2020&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"&gt;December&amp;#160;31,&lt;br /&gt; 2019&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: justify; text-indent: 10pt"&gt;Assets:&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="width: 46%; font-size: 8pt; text-align: justify; text-indent: 10pt"&gt;Cash and marketable securities held in Trust Account&lt;/td&gt;&lt;td style="width: 5%; font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 11%; font-size: 8pt; text-align: center"&gt;1&lt;/td&gt;&lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%; font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font-size: 8pt; text-align: right"&gt;5,967,947&lt;/td&gt;&lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%; font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font-size: 8pt; text-align: right"&gt;32,005,205&lt;/td&gt;&lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: justify; text-indent: 10pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: justify; text-indent: 10pt"&gt;Liabilities:&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: justify; text-indent: 10pt"&gt;Warrant Liability - Private Placement Warrants&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: center"&gt;3&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;$&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;&amp;#160;655,098&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;$&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 20pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 40pt; text-align: justify"&gt;The Company utilizes a Black-Scholes model approach&#13;to value the Placement Warrants at each reporting period, with changes in fair value recognized in the Statements of Operations.&#13;The estimated fair value of the warrant liability is determined using Level 3 inputs. Inherent in a binomial options pricing model&#13;are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company&#13;estimates the volatility of its common stock based on historical volatility that matches the expected remaining life of the warrants.&#13;The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the&#13;expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual&#13;term. The dividend rate is based on the historical rate, which the Company anticipates to remain at zero.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 40pt; text-align: justify"&gt;The significant unobservable inputs used in&#13;the Black-Scholes model to measure the warrant liabilities that are categorized within Level 3 of the fair value hierarchy are&#13;as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 12pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;As of&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 70%"&gt;Stock price&lt;/td&gt;&lt;td style="width: 10%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;24.50&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;Strike price&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;Term (in years)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;Volatility&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.4&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;Dividend yield&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td&gt;Fair value of private warrants&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;4.81&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 40pt; text-align: justify"&gt;The following table provides a summary of the&#13;changes in fair value of the Company&amp;#8217;s Level 3 financial instruments that are measured at fair value on a recurring basis:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"&gt;Warrant Liability&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-size: 8pt"&gt;Fair value as of December 31, 2019&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="width: 70%; font-size: 8pt; text-align: left; padding-bottom: 1pt"&gt;Change in valuation inputs or other assumptions&lt;/td&gt;&lt;td style="width: 10%; font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 18%; font-size: 8pt; text-align: right"&gt;655,098&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-size: 8pt; padding-bottom: 2.5pt"&gt;Fair value as of December 31, 2020&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: right"&gt;655,098&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 40pt; text-align: justify"&gt;There were no transfers between Levels 1, 2&#13;or 3 during the year ended December&amp;#160;31, 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;The Company evaluates&#13;subsequent events and transactions that occur after the consolidated balance sheet date up to the date that the financial&#13;statements were issued. Based upon this review, other than as described below and in Note 2, the Company did not identify any&#13;subsequent events that would have required adjustment or disclosure in the financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"&gt;&lt;i&gt;Nasdaq Compliance&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;On January 15, 2021, the&#13;Company received notice from the Nasdaq that a Nasdaq Hearings Panel (&amp;#8220;Panel&amp;#8221;) had granted the Company&amp;#8217;s request&#13;to continue its listing on Nasdaq through May 24, 2021 (&amp;#8220;Extended Date&amp;#8221;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;On January 4, 2021, the&#13;Company received a notice from the Staff stating that the Company&amp;#8217;s failure to hold an annual stockholder meeting for the&#13;fiscal year ended December 31, 2019 by December 31, 2020, as required by Nasdaq Listing Rule 5820, could serve as an additional&#13;basis for delisting the Company&amp;#8217;s securities from Nasdaq. The Company requested a hearing before the Panel to appeal the&#13;Staff&amp;#8217;s determination with respect to both notices and the hearing was held on January 14, 2021. The Panel&amp;#8217;s decision&#13;is subject to certain conditions, including that the Company will have completed its proposed business combination (the &amp;#8220;Business&#13;Combination&amp;#8221;) with NeuroRx on or before the Extended Date and that the combined company will have demonstrated compliance&#13;with all requirements for initial listing on Nasdaq. While the Company expects to complete the Business Combination by the Extended&#13;Date, the Company cannot assure you that it will be able to do so.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 40pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt"&gt;&lt;i&gt;Subscription Agreement&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 40pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;On March 12, 2021, the&#13;Company entered into subscription agreements (&amp;#8220;Subscription Agreements&amp;#8221;) with certain qualified institutional buyers&#13;and institutional accredited investors (collectively, the &amp;#8220;PIPE Investors&amp;#8221;), pursuant to which the Company will, substantially&#13;concurrently with, and contingent upon, the consummation of the Merger, issue an aggregate of 1,000,000 shares of the Company Common&#13;Stock, par value $0.001 per share, to the PIPE Investors at a price of $10.00 per share, for aggregate gross proceeds to the Company&#13;of $10,000,000 (the &amp;#8220;PIPE&amp;#8221;). The closing of the PIPE is conditioned upon, among other things, (i)&amp;#160;the substantially&#13;concurrent consummation of the Merger, (ii)&amp;#160;the accuracy of all representations and warranties of the Company and the PIPE&#13;Investors in the Subscription Agreements, and the performance of all covenants of the Company and the PIPE Investors under the&#13;Subscription Agreements, (iii) the shares of the Company Common Stock shall have been approved for listing on the Nasdaq Capital&#13;Market, subject to official notice of issuance, and (iv) the Merger Agreement shall not have been terminated or rescinded, and&#13;no amendment, waiver or modification shall have occurred thereunder that would materially adversely affect the economic benefits&#13;that the PIPE Investor would reasonably expect to receive under the Subscription Agreement without having received the PIPE Investor&amp;#8217;s&#13;prior written consent (not to be unreasonably withheld, conditioned, or delayed).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt"&gt;&lt;i&gt;Amendment to the Merger Agreement&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;On March 19, 2021, the&#13;Company entered into a second amendment (&amp;#8220;Amendment&amp;#8221;) to the Merger Agreement with NeuroRx and Merger Sub. The Amendment&#13;extends the outside date by which the parties must consummate the Merger from April 23, 2021 to May 24, 2021.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt"&gt;&lt;i&gt;Legal Proceedings&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;In connection with the proposed&#13;Merger with NeuroRx, a purported stockholder of the Company has filed a lawsuit and other purported stockholders have threatened&#13;to file lawsuits alleging breaches of fiduciary duty and violations of the disclosure requirements of the Exchange Act. The Company&#13;intends to defend the matters vigorously. These matters are in the early stages and the Company is currently unable to reasonably&#13;determine the outcome or estimate any potential losses, and, as such, has not recorded a loss contingency.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;&amp;#160;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;The accompanying consolidated&#13;financial statements are presented in conformity with accounting principles generally accepted in the United States of America&#13;(&amp;#8220;GAAP&amp;#8221;) and pursuant to the rules and regulations of the SEC.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;The accompanying consolidated&#13;financial statements include the accounts of the Company and its majority owned subsidiary where the Company has the ability to&#13;exercise control. All significant intercompany balances and transactions have been eliminated in consolidation. Activities in relation&#13;to the noncontrolling interest are not considered to be significant and are, therefore, not presented in the accompanying consolidated&#13;financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <BRPAU:EmergingGrowthCompanyPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;The Company is an &amp;#8220;emerging&#13;growth company,&amp;#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act&#13;of 2012 (the &amp;#8220;JOBS Act&amp;#8221;), and it may take advantage of certain exemptions from various reporting requirements that&#13;are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required&#13;to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding&#13;executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding&#13;advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;Further, Section 102(b)(1)&#13;of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards&#13;until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not&#13;have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting&#13;standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements&#13;that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt&#13;out of such extended transition period which means that when a standard is issued or revised and it has different application dates&#13;for public or private companies, the Company, as an emerging growth company, will adopt the new or revised standard at the time&#13;private companies adopt the new or revised standard. This may make comparison of the Company&amp;#8217;s consolidated financial statements&#13;with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using&#13;the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;</BRPAU:EmergingGrowthCompanyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;The preparation of consolidated&#13;financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts&#13;of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported&#13;amounts of revenues and expenses during the reporting period.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 60pt"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;Making estimates requires&#13;management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition,&#13;situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating&#13;its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could&#13;differ significantly from the Company&amp;#8217;s estimates.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;The Company considers all&#13;short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did&#13;not have any cash equivalents as of December 31, 2020 and 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;&amp;#160;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:MarketableSecuritiesPolicy contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;At December 31, 2020 and&#13;2019, the assets held in the Trust Account were held in money market funds, which are invested in U.S. Treasury securities. Through&#13;December 31, 2020, the Company has withdrawn $716,788 of interest from the Trust Account in order to pay its franchise and income&#13;taxes, of which $161,430 was withdrawn during the year ended December 31, 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:StockholdersEquityPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;The Company accounts for&#13;its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;)&#13;Topic 480 &amp;#8220;Distinguishing Liabilities from Equity.&amp;#8221; Common stock subject to mandatory redemption is classified as a&#13;liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features&#13;redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events&#13;not solely within the Company&amp;#8217;s control) is classified as temporary equity. At all other times, common stock is classified&#13;as stockholders&amp;#8217; equity. The Company&amp;#8217;s common stock features certain redemption rights that are considered to be outside&#13;of the Company&amp;#8217;s control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible&#13;redemption is presented at redemption value as temporary equity, outside of the stockholders&amp;#8217; equity section of the Company&amp;#8217;s&#13;balance sheets. At December 31, 2020, there are no shares of common stock subject to possible redemption.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:StockholdersEquityPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;The Company complies with&#13;the accounting and reporting requirements of ASC Topic 740 &amp;#8220;Income Taxes,&amp;#8221; which requires an asset and liability approach&#13;to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences&#13;between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts,&#13;based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation&#13;allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;ASC Topic 740 prescribes&#13;a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken&#13;or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be&#13;sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized&#13;tax benefits as income tax expense. As of December 31, 2020 and 2019, there were no unrecognized tax benefits and no amounts accrued&#13;for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments,&#13;accruals or material deviation from its position.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;The Company may be subject&#13;to potential examination by federal, state and city taxing authorities in the areas of income taxes. These potential examinations&#13;may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance&#13;with federal, state and city tax laws. The Company&amp;#8217;s management does not expect that the total amount of unrecognized tax&#13;benefits will materially change over the next twelve months.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;On March 27, 2020, the&#13;CARES Act was enacted in response to COVID-19 pandemic. Under ASC 740, the effects of changes in tax rates and laws are recognized&#13;in the period which the new legislation is enacted. The CARES Act made various tax law changes including among other things (i)&#13;increasing the limitation under Section 163(j) of the Internal Revenue Code of 1986, as amended (the &amp;#8220;IRC&amp;#8221;) for 2019&#13;and 2020 to permit additional expensing of interest (ii) enacting a technical correction so that qualified improvement property&#13;can be immediately expensed under IRC Section 168(k), (iii) making modifications to the federal net operating loss rules including&#13;permitting federal net operating losses incurred in 2018, 2019, and 2020 to be carried back to the five preceding taxable years&#13;in order to generate a refund of previously paid income taxes and (iv) enhancing the recoverability of alternative minimum tax&#13;credits. Given the Company&amp;#8217;s full valuation allowance position, the CARES Act did not have&#13;an impact on the financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;Financial instruments that&#13;potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at&#13;times may exceed the Federal depository insurance coverage limit of $250,000. The Company has not experienced losses on this account&#13;and management believes the Company is not exposed to significant risks on such account.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;Management does not believe&#13;that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the&#13;Company&amp;#8217;s consolidated financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left; text-indent: 0pt"&gt;Deferred tax assets&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="width: 56%; font-size: 8pt; text-align: left; text-indent: 0pt; padding-left: 10pt"&gt;Net operating loss carryforward&lt;/td&gt;&lt;td style="width: 8%; font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 8pt; text-align: right"&gt;105,559&lt;/td&gt;&lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left; padding-bottom: 1pt; text-indent: 0pt; padding-left: 10pt"&gt;Unrealized gain on marketable securities&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left; text-indent: 0pt"&gt;Total deferred tax assets&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;105,559&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left; padding-bottom: 1pt; text-indent: 0pt"&gt;Valuation Allowance&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"&gt;(105,559&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left; padding-bottom: 2.5pt; text-indent: 0pt"&gt;Deferred tax assets, net valuation allowance&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 8pt"&gt;Federal&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 56%; font-size: 8pt; text-indent: 0pt; padding-left: 10pt"&gt;Current&lt;/td&gt;&lt;td style="width: 8%; font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 8pt; text-align: right"&gt;17,841&lt;/td&gt;&lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 8pt; text-align: right"&gt;102,332&lt;/td&gt;&lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 8pt; text-indent: 0pt; padding-left: 10pt"&gt;Deferred&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;(87,480&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;2,936&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-indent: 0pt"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left; text-indent: 0pt"&gt;State and Local&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-size: 8pt; text-indent: 0pt; padding-left: 10pt"&gt;Current&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 8pt; text-indent: 0pt; padding-left: 10pt"&gt;Deferred&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;(18,079&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 10pt"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left; padding-bottom: 1pt; text-indent: 0pt"&gt;Change in valuation allowance&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"&gt;105,559&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"&gt;(21,062&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-indent: 0pt"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left; padding-bottom: 2.5pt; text-indent: 0pt"&gt;Income tax provision&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: right"&gt;17,841&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: right"&gt;84,206&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="From2020-01-01to2020-12-31_custom_NonredeemableCommonStockMember" unitRef="USD" decimals="0">-1089510</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="From2019-01-01to2019-12-31_custom_NonredeemableCommonStockMember" unitRef="USD" decimals="0">-1594</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="From2020-01-01to2020-12-31_custom_RedeemableCommonStockMember" unitRef="USD" decimals="0">0</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="From2019-01-01to2019-12-31_custom_RedeemableCommonStockMember" unitRef="USD" decimals="0">703894</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <BRPAU:IncomeLossAllocableToCommonStockSubjectToPossibleRedemption contextRef="From2020-01-01to2020-12-31_custom_NonredeemableCommonStockMember" unitRef="USD" decimals="0">0</BRPAU:IncomeLossAllocableToCommonStockSubjectToPossibleRedemption>
    <BRPAU:IncomeLossAllocableToCommonStockSubjectToPossibleRedemption contextRef="From2019-01-01to2019-12-31_custom_NonredeemableCommonStockMember" unitRef="USD" decimals="0">0</BRPAU:IncomeLossAllocableToCommonStockSubjectToPossibleRedemption>
    <us-gaap:InterestIncomeDebtSecuritiesOperating contextRef="From2020-01-01to2020-12-31_custom_RedeemableCommonStockMember" unitRef="USD" decimals="0">0</us-gaap:InterestIncomeDebtSecuritiesOperating>
    <us-gaap:InterestIncomeDebtSecuritiesOperating contextRef="From2019-01-01to2019-12-31_custom_RedeemableCommonStockMember" unitRef="USD" decimals="0">922211</us-gaap:InterestIncomeDebtSecuritiesOperating>
    <BRPAU:InterestAvailableToBeWithdrawnForPaymentOfTaxes contextRef="From2020-01-01to2020-12-31_custom_RedeemableCommonStockMember" unitRef="USD" decimals="0">0</BRPAU:InterestAvailableToBeWithdrawnForPaymentOfTaxes>
    <BRPAU:InterestAvailableToBeWithdrawnForPaymentOfTaxes contextRef="From2019-01-01to2019-12-31_custom_RedeemableCommonStockMember" unitRef="USD" decimals="0">-218317</BRPAU:InterestAvailableToBeWithdrawnForPaymentOfTaxes>
    <us-gaap:ProceedsFromBankDebt contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">161430</us-gaap:ProceedsFromBankDebt>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">0</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">416571</us-gaap:OperatingLossCarryforwards>
    <us-gaap:ProfitLoss contextRef="From2020-01-01to2020-12-31_custom_NonredeemableCommonStockMember" unitRef="USD" decimals="0">-1089510</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="From2019-01-01to2019-12-31_custom_NonredeemableCommonStockMember" unitRef="USD" decimals="0">-1594</us-gaap:ProfitLoss>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2021-05-07" unitRef="Shares" decimals="INF">2687912</dei:EntityCommonStockSharesOutstanding>
    <dei:AmendmentDescription contextRef="From2020-01-01to2020-12-31">Big Rock Partners Acquisition Corp. (the &#8220;Company&#8221;) is filing this Amendment No. 1 on Form 10-K/A (the &#8220;Amendment&#8221;) to the Annual Report on Form 10-K for the year ended December 31, 2020, originally filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on April 1, 2021 (the &#8220;Original 10-K&#8221;) as a comprehensive amendment to amend and restate its financial statements and related footnote disclosures as of December 31, 2020. Accordingly, the following sections of the Original 10-K are being amended and restated hereby: Part I, Item 1A &#8220;Risk Factors&#8221;, Part II, Item 7 &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221;, Part II, Item 8 &#8220;Financial Statements and Supplementary Data&#8221;, Part II, Item 9A &#8220;Controls and Procedures&#8221; and Part IV, Item 15, &#8220;Exhibits and Financial Statement Schedules&#8221;. In addition, as required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended (&#8220;Exchange Act&#8221;), new certifications by our principal executive officer and principal financial officer are being filed as exhibits to this Amendment. As noted above, Part II, Item 8 &#8220;Financial Statements and Supplementary Data&#8221; of this Amendment reflects the restatement of financial information included in the Company&#8217;s Original 10-K filed with the SEC. This Amendment supersedes the financial information included in the Original 10-K. Except as described above, no other changes have been made to the Original 10-K. The Original 10-K continues to speak as of the date of the Original 10-K, and we have not updated the disclosures contained therein to reflect any events which occurred at a date subsequent to the filing of the Original 10-K. Accordingly, this Amendment should be read in conjunction with the Original 10-K and our filings with the SEC subsequent to the date of the Original 10-K.</dei:AmendmentDescription>
    <us-gaap:DerivativeLiabilitiesCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">0</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">655098</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent contextRef="AsOf2020-12-31_srt_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">0</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent contextRef="AsOf2020-12-31_srt_RestatementAdjustmentMember" unitRef="USD" decimals="0">655098</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent contextRef="AsOf2020-12-31_us-gaap_FairValueInputsLevel3Member" unitRef="USD" decimals="0">655098</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent contextRef="AsOf2019-12-31_us-gaap_FairValueInputsLevel3Member" unitRef="USD" decimals="0">0</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-655098</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="From2020-01-01to2020-12-31_srt_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="From2020-01-01to2020-12-31_srt_RestatementAdjustmentMember" unitRef="USD" decimals="0">-655098</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:AccountingChangesAndErrorCorrectionsTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company previously accounted for its outstanding&#13;Public Warrants and Private Placement Warrants issued in connection with its Initial Public Offering as&#13;components of equity instead of as derivative liabilities.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In connection with the audit of the Company&amp;#8217;s&#13;financial statements for the period ended December 31, 2020, the Company&amp;#8217;s management further evaluated the warrants under&#13;Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;) Subtopic 815-40, Contracts in Entity&amp;#8217;s Own Equity. &amp;#160;ASC Section&#13;815-40-15 addresses equity versus liability treatment and classification of equity-linked financial instruments, including warrants,&#13;and states that a warrant may be classified as a component of equity only if, among other things, the warrant is indexed to the&#13;issuer&amp;#8217;s common stock. &amp;#160;Under ASC Section 815-40-15, a warrant is not indexed to the issuer&amp;#8217;s common stock if&#13;the terms of the warrant require an adjustment to the exercise price upon a specified event and that event is not an input to the&#13;fair value of the warrant. &amp;#160;Based on management&amp;#8217;s evaluation, the Company&amp;#8217;s audit committee, in consultation with&#13;management and after discussion with the Company&amp;#8217;s independent registered public accounting firm, concluded that the Company&amp;#8217;s&#13;Private Placement Warrants are not indexed to the Company&amp;#8217;s common shares in the manner contemplated by ASC Section 815-40-15&#13;because the holder of the instrument is not an input into the pricing of a fixed-for-fixed option on equity shares.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As a result of the above, the Company&#13;should have classified the Private Placement Warrants as derivative liabilities in its previously issued financial&#13;statements. Under this accounting treatment, the Company is required to measure the fair value of the warrants at the end of&#13;each reporting period and recognize changes in the fair value from the prior period in the Company&amp;#8217;s operating results&#13;for the current period (See Notes 3 and 10).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&amp;#8217;s accounting for the Private&#13;Placement Warrants as components of equity instead of as derivative liabilities did not have any effect on the Company&amp;#8217;s&#13;previously reported operating expenses, cash flows or cash.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;As Previously Reported&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Adjustment&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;As Restated&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Balance Sheet as of December 31, 2020 (audited)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="width: 64%"&gt;&lt;font style="font-size: 8pt"&gt;Warrant liability&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;655,098&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;655,098&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Total liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3,281,546&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;655,098&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3,936,644&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;(Accumulated deficit)/retained earnings&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(64,917&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(655,098&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(720,015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Total stockholders&amp;#8217; equity&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,768,859&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(655,098&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,113,761&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Statement of Operations for the Year Ended December 31, 2020 (audited)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Change in fair value of warrant liability&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(655,098&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(655,098&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Other income, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;490,835&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(655,098&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(164,263&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;(Loss) income before provision for income taxes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(416,571&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(655,098&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(1,071,669&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Net (loss) income&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(434,412&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(655,098&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(1,089,510&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Basic and diluted net loss per common share, Non-redeemable common stock&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(0.16&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(0. 24&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(0. 40&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Statement of Cash Flows for the Year Ended December 31, 2020 (audited)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Cash flow from operating activities:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Net loss&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(434,412&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(655,098&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(1,089,510&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Adjustments to reconcile net loss to net cash and used in operating activities:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Change in fair value of warrant liability&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;655,098&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;655,098&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Supplemental disclosure of non-cash investing and financing activities:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Initial measurement of warrants issued in connection with the Initial Public Offering accounted for as liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;655,098&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;655,098&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:AccountingChangesAndErrorCorrectionsTextBlock>
    <us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;As Previously Reported&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Adjustment&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;As Restated&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Balance Sheet as of December 31, 2020 (audited)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="width: 64%"&gt;&lt;font style="font-size: 8pt"&gt;Warrant liability&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;655,098&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;655,098&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Total liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3,281,546&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;655,098&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3,936,644&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;(Accumulated deficit)/retained earnings&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(64,917&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(655,098&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(720,015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Total stockholders&amp;#8217; equity&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,768,859&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(655,098&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,113,761&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Statement of Operations for the Year Ended December 31, 2020 (audited)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Change in fair value of warrant liability&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(655,098&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(655,098&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Other income, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;490,835&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(655,098&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(164,263&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;(Loss) income before provision for income taxes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(416,571&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(655,098&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(1,071,669&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Net (loss) income&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(434,412&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(655,098&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(1,089,510&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Basic and diluted net loss per common share, Non-redeemable common stock&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(0.16&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(0. 24&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(0. 40&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Statement of Cash Flows for the Year Ended December 31, 2020 (audited)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Cash flow from operating activities:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Net loss&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(434,412&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(655,098&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(1,089,510&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Adjustments to reconcile net loss to net cash and used in operating activities:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Change in fair value of warrant liability&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;655,098&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;655,098&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Supplemental disclosure of non-cash investing and financing activities:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Initial measurement of warrants issued in connection with the Initial Public Offering accounted for as liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;655,098&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;655,098&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock>
    <us-gaap:DerivativesPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 40pt; text-align: justify"&gt;The Company accounts for warrants as either&#13;equity-classified or liability-classified instruments based on an assessment of the warrant&amp;#8217;s specific terms and applicable&#13;authoritative guidance in Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;) Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;)&#13;480, Distinguishing Liabilities from Equity (&amp;#8220;ASC 480&amp;#8221;) and ASC 815,&amp;#160;Derivatives and Hedging&amp;#160;(&amp;#8220;ASC&#13;815&amp;#8221;). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the&#13;definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification&#13;under ASC 815, including whether the warrants are indexed to the Company&amp;#8217;s own common shares and whether the warrant holders&#13;could potentially require &amp;#8220;net cash settlement&amp;#8221; in a circumstance outside of the Company&amp;#8217;s control, among other&#13;conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time&#13;of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 40pt; text-align: justify"&gt;For issued or modified warrants that meet all&#13;of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital&#13;at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants&#13;are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes&#13;in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. The fair&#13;value of the Private Placement Warrants was estimated using a Black-Scholes valuation approach (see Note 12).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 40pt; text-align: justify"&gt;Net income (loss) per share is computed by dividing&#13;net income by the weighted-average number of shares of common stock outstanding during the period, excluding shares of common stock&#13;subject to forfeiture. The Company has not considered the effect of (1) warrants sold in the Initial Public Offering and private&#13;placement to purchase 3,586,250 shares of common stock, (2) rights sold in the Initial Public Offering and private placement that&#13;convert into 717,250 shares of common stock and (3) 600,000 shares of common stock, warrants to purchase 300,000 shares of common&#13;stock and rights that convert into 60,000 shares of common stock in the unit purchase option sold to the underwriter, in the calculation&#13;of diluted (loss) income per share, since the exercise of the warrants are contingent upon the occurrence of future events and&#13;the inclusion of such warrants would be anti-dilutive.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 40pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0.7pt 0 0pt; text-indent: 40pt; text-align: justify"&gt;The Company&amp;#8217;s consolidated statements&#13;of operations include a presentation of income (loss) per share for common shares subject to possible redemption in a manner similar&#13;to the two-class method of income (loss) per share. Net income (loss) per common share, basic and diluted, for Common stock subject&#13;to possible redemption is calculated by dividing the proportionate share of income or loss on marketable securities held by the&#13;Trust Account, net of applicable franchise and income taxes, by the weighted average number of shares of Common stock subject to&#13;possible redemption outstanding since original issuance.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0.7pt 0 0pt; text-indent: 40pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0.7pt 0 0pt; text-indent: 40pt; text-align: justify"&gt;Net income (loss) per share, basic&#13;and diluted, for non-redeemable common stock is calculated by dividing the net income (loss), adjusted for income or loss on marketable&#13;securities attributable to Common stock subject to possible redemption, by the weighted average number of non-redeemable common&#13;stock outstanding for the period.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0.7pt 0 0pt; text-indent: 40pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0.7pt 0 0pt; text-indent: 40pt; text-align: justify"&gt;Non-redeemable common stock includes&#13;Founder Shares and non-redeemable shares of common stock as these shares do not have any redemption features. Non-redeemable common&#13;stock participates in the income or loss on marketable securities based on non-redeemable shares&amp;#8217; proportionate interest.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0.7pt 0 0pt; text-indent: 40pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 40pt; text-align: justify"&gt;The following table reflects the calculation&#13;of basic and diluted net income (loss) per common share (in dollars, except per share amounts):&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="7" style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: center"&gt;Year Ended December 31,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-style: italic; text-align: left"&gt;Common stock subject to possible redemption&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;Numerator: Earnings allocable to Common stock subject to possible redemption&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 0pt; width: 56%; font-size: 8pt; text-align: left; text-indent: 10pt"&gt;Interest earned on marketable securities held in Trust Account&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; width: 8%; font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; width: 1%; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; width: 12%; font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; width: 1%; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; width: 8%; font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; width: 1%; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; width: 12%; font-size: 8pt; text-align: right"&gt;922,211&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; width: 1%; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 0pt; font-size: 8pt; text-align: left; padding-bottom: 1pt; text-indent: 10pt"&gt;Less: interest available to be withdrawn for payment of taxes&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: right"&gt;(218,317&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 0pt; font-size: 8pt; text-align: left; padding-bottom: 2.5pt; text-indent: 30pt"&gt;Net income attributable&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;703,894&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;Denominator: Weighted Average Common stock subject to possible redemption&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted weighted average shares outstanding, Common stock subject to possible redemption&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;546,586&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;4,555,229&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted net income per share, Common stock subject to possible redemption&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;0.15&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-style: italic; text-align: left"&gt;Non-Redeemable Common Stock&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;Numerator: Net Loss minus Net Earnings&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 0pt; font-size: 8pt; text-align: left; text-indent: 10pt"&gt;Net loss&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: right"&gt;(1,089,510&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: right"&gt;(1,594&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 0pt; font-size: 8pt; text-align: left; padding-bottom: 1pt; text-indent: 10pt"&gt;Net income allocable to Common stock subject to possible redemption&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 0pt; font-size: 8pt; text-align: left; padding-bottom: 2.5pt; text-indent: 30pt"&gt;Non-Redeemable Net Loss&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;(1,089,510&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;(1,594&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;Denominator: Weighted Average Non-redeemable common stock&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted weighted average shares outstanding, Non-redeemable common stock&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;2,736,258&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;2,783,021&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted net loss per share, Non-redeemable common stock&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;(0.40&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;(0.11&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt"&gt;&lt;b&gt;&amp;#160;&amp;#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="7" style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: center"&gt;Year Ended December 31,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-style: italic; text-align: left"&gt;Common stock subject to possible redemption&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;Numerator: Earnings allocable to Common stock subject to possible redemption&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 0pt; width: 56%; font-size: 8pt; text-align: left; text-indent: 10pt"&gt;Interest earned on marketable securities held in Trust Account&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; width: 8%; font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; width: 1%; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; width: 12%; font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; width: 1%; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; width: 8%; font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; width: 1%; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; width: 12%; font-size: 8pt; text-align: right"&gt;922,211&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; width: 1%; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 0pt; font-size: 8pt; text-align: left; padding-bottom: 1pt; text-indent: 10pt"&gt;Less: interest available to be withdrawn for payment of taxes&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: right"&gt;(218,317&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 0pt; font-size: 8pt; text-align: left; padding-bottom: 2.5pt; text-indent: 30pt"&gt;Net income attributable&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;703,894&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;Denominator: Weighted Average Common stock subject to possible redemption&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted weighted average shares outstanding, Common stock subject to possible redemption&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;546,586&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;4,555,229&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted net income per share, Common stock subject to possible redemption&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;0.15&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-style: italic; text-align: left"&gt;Non-Redeemable Common Stock&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;Numerator: Net Loss minus Net Earnings&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 0pt; font-size: 8pt; text-align: left; text-indent: 10pt"&gt;Net loss&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: right"&gt;(1,089,510&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: right"&gt;(1,594&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 0pt; font-size: 8pt; text-align: left; padding-bottom: 1pt; text-indent: 10pt"&gt;Net income allocable to Common stock subject to possible redemption&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 0pt; font-size: 8pt; text-align: left; padding-bottom: 2.5pt; text-indent: 30pt"&gt;Non-Redeemable Net Loss&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;(1,089,510&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;(1,594&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left"&gt;Denominator: Weighted Average Non-redeemable common stock&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted weighted average shares outstanding, Non-redeemable common stock&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;2,736,258&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;2,783,021&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted net loss per share, Non-redeemable common stock&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;(0.40&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-indent: 0pt; padding-left: 0pt; font-size: 8pt; font-weight: bold; text-align: right"&gt;(0.11&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <BRPAU:DerivativeFinancialInstrumentsPolicy contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 40pt; text-align: justify"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;The&#13;Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify&#13;as embedded derivatives in accordance with ASC Topic 815, &amp;#8220;Derivatives and Hedging&amp;#8221;. For derivative financial instruments&#13;that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and&#13;is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification&#13;of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at&#13;the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on&#13;whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;</BRPAU:DerivativeFinancialInstrumentsPolicy>
    <us-gaap:DerivativesAndFairValueTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;&lt;b&gt;&lt;i&gt;Warrants&lt;/i&gt;&lt;/b&gt;&#13;&amp;#8212; Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of&#13;the Public Warrants. The Public Warrants will become exercisable on the later of the completion of a Business Combination and November&#13;22, 2018; provided in that the Company has an effective registration statement under the Securities Act covering the shares of&#13;common stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available. The Company&#13;has agreed that as soon as practicable, the Company will use its best efforts to file with the SEC a registration statement for&#13;the registration, under the Securities Act, of the shares of common stock issuable upon exercise of the Public Warrants. The Company&#13;will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement,&#13;and a current prospectus relating thereto, until the expiration of the Public Warrants in accordance with the provisions of the&#13;warrant agreement. Notwithstanding the foregoing, if a registration statement covering the shares of common stock issuable upon&#13;exercise of the Public Warrants is not effective 90 days following the consummation of Business Combination, warrant holders may,&#13;until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain&#13;an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9)&#13;of the Securities Act, provided that such exemption is available. If that exemption, or another exemption, is not available, holders&#13;will not be able to exercise their warrants on a cashless basis. The Public Warrants will expire five years after the completion&#13;of a Business Combination or earlier upon redemption or liquidation.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;The Company may redeem&#13;the Public Warrants:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0pt; width: 3%; padding-right: 0.8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; width: 3%; padding-right: 0.8pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#9679;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; width: 94%; padding-right: 0.8pt; text-align: justify"&gt;&lt;font style="font-size: 8pt"&gt;in whole and not in part;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-right: 0.8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-right: 0.8pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#9679;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-right: 0.8pt; text-align: justify"&gt;&lt;font style="font-size: 8pt"&gt;at a price of $0.01 per warrant;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-right: 0.8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-right: 0.8pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#9679;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-right: 0.8pt; text-align: justify"&gt;&lt;font style="font-size: 8pt"&gt;at any time during the exercise period;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-right: 0.8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-right: 0.8pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#9679;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-right: 0.8pt; text-align: justify"&gt;&lt;font style="font-size: 8pt"&gt;upon a minimum of 30 days&amp;#8217; prior written notice of redemption; and&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-right: 0.8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-right: 0.8pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#9679;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-right: 0.8pt; text-align: justify"&gt;&lt;font style="font-size: 8pt"&gt;if, and only if, the last sale price of the Company&amp;#8217;s common stock equals or exceeds $21.00 per share for any 20 trading days within a 30-trading day period ending on the third business day prior to the date on which the Company sends the notice of redemption to the warrant holders.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0pt; padding-right: 0.8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-right: 0.8pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#9679;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-indent: 0pt; padding-right: 0.8pt; text-align: justify"&gt;&lt;font style="font-size: 8pt"&gt;If, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such warrants.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;If the Company calls the&#13;Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants&#13;to do so on a &amp;#8220;cashless basis,&amp;#8221; as described in the warrant agreement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;The exercise price and number&#13;of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event&#13;of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted&#13;for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net&#13;cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company&#13;liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants,&#13;nor will they receive any distribution from the Company&amp;#8217;s assets held outside of the Trust Account with the respect to such&#13;warrants. Accordingly, the warrants may expire worthless.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:DerivativesAndFairValueTextBlock>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"&gt;December 31, 2020&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"&gt;December 31, 2019&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 56%; font-size: 8pt; text-align: left; text-indent: 0pt"&gt;Statutory federal income tax rate&lt;/td&gt;&lt;td style="width: 8%; font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 12%; font-size: 8pt; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 8%; font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 12%; font-size: 8pt; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left; text-indent: 0pt"&gt;State taxes, net of federal tax benefit&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;4.3&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;0.0&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-size: 8pt; text-indent: 0pt"&gt;True-ups&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;(1.7&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;)%&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;0.4&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 8pt; text-indent: 0pt"&gt;Change in FV of warrant liabilities&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;&amp;#160;(15.5&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;)%&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;&amp;#160;0.0&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left; padding-bottom: 1pt; text-indent: 0pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"&gt;(9.9&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;)%&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"&gt;(4.3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left; padding-bottom: 2.5pt; text-indent: 0pt"&gt;Income tax provision&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: right"&gt;(1.7&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 8pt; text-align: left"&gt;)%&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: right"&gt;17.1&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 8pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <BRPAU:EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiabilities contextRef="From2020-01-01to2020-12-31" unitRef="Percent" decimals="INF">-.1550</BRPAU:EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiabilities>
    <BRPAU:EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiabilities contextRef="From2019-01-01to2019-12-31" unitRef="Percent" decimals="INF">.0000</BRPAU:EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiabilities>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: justify"&gt;Description&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"&gt;Level&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"&gt;December&amp;#160;31,&lt;br /&gt; 2020&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"&gt;December&amp;#160;31,&lt;br /&gt; 2019&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: justify; text-indent: 10pt"&gt;Assets:&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="width: 46%; font-size: 8pt; text-align: justify; text-indent: 10pt"&gt;Cash and marketable securities held in Trust Account&lt;/td&gt;&lt;td style="width: 5%; font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 11%; font-size: 8pt; text-align: center"&gt;1&lt;/td&gt;&lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%; font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font-size: 8pt; text-align: right"&gt;5,967,947&lt;/td&gt;&lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%; font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font-size: 8pt; text-align: right"&gt;32,005,205&lt;/td&gt;&lt;td style="width: 1%; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: justify; text-indent: 10pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: justify; text-indent: 10pt"&gt;Liabilities:&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: justify; text-indent: 10pt"&gt;Warrant Liability - Private Placement Warrants&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: center"&gt;3&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;$&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;&amp;#160;655,098&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;$&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <BRPAU:ScheduleOfWarrantLiabilityValuationAssumptionsTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 12pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;As of&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 70%"&gt;Stock price&lt;/td&gt;&lt;td style="width: 10%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;24.50&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;Strike price&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;Term (in years)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;Volatility&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.4&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;Dividend yield&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td&gt;Fair value of private warrants&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;4.81&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</BRPAU:ScheduleOfWarrantLiabilityValuationAssumptionsTableTextBlock>
    <us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"&gt;Warrant Liability&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-size: 8pt"&gt;Fair value as of December 31, 2019&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="width: 70%; font-size: 8pt; text-align: left; padding-bottom: 1pt"&gt;Change in valuation inputs or other assumptions&lt;/td&gt;&lt;td style="width: 10%; font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 18%; font-size: 8pt; text-align: right"&gt;655,098&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-size: 8pt; padding-bottom: 2.5pt"&gt;Fair value as of December 31, 2020&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: right"&gt;655,098&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock>
    <us-gaap:SharePrice contextRef="AsOf2020-12-31" unitRef="USDPShares" decimals="INF">24.50</us-gaap:SharePrice>
    <BRPAU:StrikePrice contextRef="AsOf2020-12-31" unitRef="USDPShares" decimals="INF">11.50</BRPAU:StrikePrice>
    <BRPAU:FairValueOfPrivateWarrants contextRef="AsOf2020-12-31" unitRef="USDPShares" decimals="INF">4.81</BRPAU:FairValueOfPrivateWarrants>
    <BRPAU:WarrantLiabilityFairValueAssumptionsExpectedDividendRate contextRef="From2020-01-01to2020-12-31" unitRef="Percent" decimals="INF">.0000</BRPAU:WarrantLiabilityFairValueAssumptionsExpectedDividendRate>
    <BRPAU:WarrantLiabilityFairValueAssumptionsRiskFreeInterestRate contextRef="From2020-01-01to2020-12-31" unitRef="Percent" decimals="INF">.0040</BRPAU:WarrantLiabilityFairValueAssumptionsRiskFreeInterestRate>
    <BRPAU:WarrantLiabilityFairValueAssumptionsExpectedVolatilityRate contextRef="From2020-01-01to2020-12-31" unitRef="Percent" decimals="INF">.2500</BRPAU:WarrantLiabilityFairValueAssumptionsExpectedVolatilityRate>
    <BRPAU:WarrantLiabilityFairValueAssumptionsExpectedTerm contextRef="From2020-01-01to2020-12-31">P5Y</BRPAU:WarrantLiabilityFairValueAssumptionsExpectedTerm>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 40pt; text-align: justify"&gt;The Company applies ASC 820, &lt;i&gt;Fair Value Measurement&lt;/i&gt;&#13;(&amp;#34;ASC 820&amp;#34;), which establishes framework for measuring fair value and clarifies the definition of fair value within that&#13;framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer&#13;a liability in the Company&amp;#8217;s principal or most advantageous market in an orderly transaction between market participants&#13;on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable&#13;inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market&#13;participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent&#13;of the reporting entity. Unobservable inputs reflect the entity&amp;#8217;s own assumptions based on market data and the entity&amp;#8217;s&#13;judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based&#13;on the best information available in the circumstances.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 40pt; text-align: justify"&gt;The valuation hierarchy is composed of three&#13;levels. The classification within the valuation hierarchy is based on the lowest level of input that is significant to the fair&#13;value measurement. The levels within the valuation hierarchy are described below:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Level 1 - Assets and liabilities with unadjusted,&#13;quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices&#13;in active markets for identical assets or liabilities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Level 2 - Inputs to the fair value measurement&#13;are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect&#13;observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Level 3 - Inputs to the fair value measurement&#13;are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the&#13;assets or liabilities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-indent: 0pt; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 40pt"&gt;The fair value of&#13;the Company&amp;#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &amp;#8220;Fair Value Measurement,&amp;#8221;&#13;approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their short-te&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;rm&#13;nature.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 40pt; text-align: justify"&gt;See Note 12 for additional information on assets&#13;and liabilities measured at fair value.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&amp;#160;&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
</xbrli:xbrl>
